question,answer,contexts,contexts_ids,ground_truth,goldPassages
What is the implication of histone lysine methylation in medulloblastoma?,"Yes, the context suggests that histone lysine methylation has significant implications in medulloblastoma. Specifically, mutations in H3K27 demethylases and aberrations in genes controlling H3K9","Context: Recent studies showed frequent mutations in histone H3 lysine 27 (H3K27)  demethylases in medulloblastomas of Group 3 and Group 4, suggesting a role for  H3K27 methylation in these tumors. Indeed, trimethylated H3K27 (H3K27me3) levels, Context: Copy number aberrations of genes with critical roles in writing, reading,  removing and blocking the state of histone lysine methylation, particularly at  H3K9, suggest that defective control of the histone code contributes to the, Context: determination of stem cell fates and has been implicated in carcinogenesis.  Consistent with our genetic data, restoration of expression of genes controlling  H3K9 methylation greatly diminishes proliferation of medulloblastoma in vitro., Context: critical genes in its development, we profiled the promoter methylation status  of 11 candidate tumour-suppressor genes (TSGs; p14(ARF), p15(INK4b), p16(INK4a),  CASP8, HIC1, EDNRB, TIMP3, TP73, TSLC1, RIZ1 and RASSF1A) in medulloblastoma, Context: concordant methylation phenotype in this disease. We conclude that epigenetic  TSG inactivation is a significant feature of medulloblastoma, and identify  RASSF1A, HIC1 and CASP8 as potentially critical genes in its pathogenesis., Context: background of partial methylation in the normal cerebellum. These data therefore  indicate that extensive methylation of RASSF1A, HIC1 and CASP8 are  tumour-specific events in medulloblastoma. Moreover, methylation of these genes","23179372, 19270706, 19270706, 14688019, 14688019, 14688019","Aberrant patterns of H3K4, H3K9, and H3K27 histone lysine methylation were shown to result in histone code alterations, which induce changes in gene expression, and affect the proliferation rate of cells in medulloblastoma.","23179372, 19270706, 23184418"
Which human gene encode for DNA polymerase θ?,"Yes, the human gene that encodes for DNA polymerase θ is POLQ. It can be found in the RefSeq database on the UCSC Genome Bioinformatics website.","Context: Electronic PCR, OrfFinder, Splign, ProSplign, RefSeq, UniGene, HomoloGene,  ProtEST, dbMHC, dbSNP, dbVar, Epigenomics, Cancer Chromosomes, Entrez Genomes  and related tools, the Map Viewer, Model Maker, Evidence Viewer, Trace Archive,, Context: immune system, during repair of CRISPR-Cas9, and in many DNA integration events.  Pol θ is a potentially important clinical target, particularly for cancers  deficient in other break repair strategies. The enzyme is uniquely able to, Context: with multifocal sharp waves and no evidence of the typical patterns associated  with Ohtahara or West syndrome. Therapy with levetiracetam and oxcarbazepine  effectively managed the seizure episodes. Investigation of genes associated with, Context: can all be found on the UCSC Genome Bioinformatics website  (http://genome.ucsc.edu), which also contains links to documentation and related  technical information., Context: Splign, RefSeq, UniGene, HomoloGene, ProtEST, dbMHC, dbSNP, Cancer Chromosomes,  Entrez Genomes and related tools, the Map Viewer, Model Maker, Evidence Viewer,  Clusters of Orthologous Groups (COGs), Retroviral Genotyping Tools, HIV-1/Human, Context: become available, it will not be effective for immunosuppressed individuals or  those who are already infected. Therefore, understanding the molecular basis for  HPV-associated cancers is still clinically relevant. Studies on genomic","21097890, 28668117, 22596016, 12519945, 18940862, 21643539",DNA polymerase theta (pol θ) is an evolutionarily conserved protein encoded by the POLQ gene in mammalian genomes,"27264557, 28668117"
Which lncRNAS are regulated by SAM68?,"Yes, there are four lncRNAs regulated by SAM68. They are Hotair, Mir155hg, as well as two new lncRNAs (SR-lncRNA-1 and","Context: 210 831. Owing to similar alternative splicing pattern to mRNAs, the concept of  lncRNA genes was put forward to help systematic understanding of lncRNAs. The 56  018 and 46 475 lncRNA genes were generated from 95 135 and 67 628 lncRNAs for, Context: depletion of SR-lncRNA-2 in Sam68-deficient 3T3-L1 cells partially rescued the  adipogenesis defect observed in these cells. Collectively, our findings define a  new role for Sam68 as a regulator of lncRNAs during adipogenic differentiation., Context: lncRNAs, we identified Hotair, Mir155hg, as well as two new lncRNAs (SR-lncRNA-1  and SR-lncRNA-2) that were regulated by Sam68, and contained consensus Sam68  binding sites. RNA stability assays showed that Sam68-deficiency decreased the, Context: step in this process involves migration to human atherosclerotic lesions. Long  non‑coding RNAs (lncRNAs) have been found to play significant roles in diverse  biological processes. The present study aimed to investigate the role of lncRNAs, Context: evaluate the methods for isolating lncRNAs by immunoprecipitation and review the  advantages, disadvantages, and applications of three widely used approaches -  microarray, tiling array, and RNA-seq - for identifying lncRNAs involved in gene, Context: information, genomic context, expression, subcellular localization,  conservation, functional evidence and other relevant information. lncRNAdb can  be searched by querying published RNA names and aliases, sequences, species and","24285305, 29137239, 29137239, 34608503, 23126680, 21112873","Hotair, Mir155hg, as well as SR-lncRNA-1 and SR-lncRNA-2 are regulated by Sam68, and contained consensus Sam68 binding sites.",29137239
What is ectopia lentis?,"Yes, ectopia lentis is a condition characterized by the subluxation of the lens resulting from the disruption of the zonular fibers. It can be associated with systemic diseases or genetic mutations such as c","Context: Ectopia lentis (EL) is a zonular disease where alteration of the zonular fibers  leads progressively to lens dislocation. It is most often associated with  systemic diseases such as Marfan syndrome, Weill-Marchesani syndrome or, Context: c.767_786del20. This deletion of 20 base pairs (bp) results in a frameshift and  an introduction of a stop codon 113 bp downstream, predicting a C-terminal  truncation of the ADAMTSL4 protein (p.Gln256ProfsX38). Expression of truncated, Context: Ectopia lentis is a genetically heterogeneous condition that is characterized by  the subluxation of the lens resulting from the disruption of the zonular fibers.  Patients with ectopia lentis commonly present with a marked loss in visual, Context: ADAMTSL4 mRNA was confirmed by RT-PCR analysis. Three of 190 local blood donors  were carriers of this mutation. CONCLUSIONS: Ectopia lentis et pupillae is associated with a number of, Context: examination. This was correlated with Sanger sequencing of ADAMTSL4 and FBN1  genes. RESULTS: Seventeen patients were examined, including one with ectopia lentis et  pupillae. Echocardiography and skeletal examination revealed no sign of systemic, Context: ectopia lentis with high myopia at 10 months. No other family member was  affected. There is no known consanguinity within the family. Genetic screening  ruled out FBN1, TGFBR2, and the known craniosynostosis hotspots (FGFR2 exon 8","20141359, 20702823, 19200529, 20702823, 22736615, 22871183",Ectopia Lentis is dislocation of the optic lens in the eye.,"25939784, 19200529, 25797933"
Describe RIblast,"Yes, RIblast is a program for sequence similarity searches that achieves a level of prediction accuracy similar to existing programs but at significantly faster speeds. It is open-source and freely available. The name RIblast likely comes","Context: essential for hypoxic survival in M. tuberculosis, but it is not known how the  regulon promotes survival. Here we report that mycobacteria, in contrast to  enteric bacteria, do not form higher-order structures (e.g. ribosomal dimers), Context: RIblast achieves a level of prediction accuracy similar to those of existing  programs, but at speeds over 64 times faster than existing programs. AVAILABILITY AND IMPLEMENTATION: The source code of RIblast is freely available, Context: autosomal-recessive encephalopathy in children that is characterized by  mutations in numerous nucleic acid repair enzymes and elevated IFN levels.  Phenotypically, patients with AGS and SLE share many similarities. Ribonuclease, Context: ribosome rescue, based on recent structural studies of them. We will also  present questions to be answered by future work., Context: to them. This mechanism enables the recognition, poly(A)-marking, and  elimination of incorrectly folded noncoding transcripts (e.g. ribosomal and  transfer RNAs)., Context: synthesis of the ribosomal subunits.","22544737, 28459942, 25500879, 27493551, 28537233, 17053056","LncRNAs play important roles in various biological processes. Although more than 58 000 human lncRNA genes have been discovered, most known lncRNAs are still poorly characterized. One approach to understanding the functions of lncRNAs is the detection of the interacting RNA target of each lncRNA. Because experimental detections of comprehensive lncRNA-RNA interactions are difficult, computational prediction of lncRNA-RNA interactions is an indispensable technique. However, the high computational costs of existing RNA-RNA interaction prediction tools prevent their application to large-scale lncRNA datasets. 'RIblast' is an ultrafast RNA-RNA interaction prediction method based on the seed-and-extension approach. RIblast discovers seed regions using suffix arrays and subsequently extends seed regions based on an RNA secondary structure energy model. Computational experiments indicate that RIblast achieves a level of prediction accuracy similar to those of existing programs, but at speeds over 64 times faster than existing programs.",28459942
Are piRNAs involved in gene silencing?,"Yes, according to the context, piRNAs are indeed involved in gene silencing. This is stated explicitly when describing how piRNAs participate in a posttranscriptional gene-silencing mechanism that results in RNA nuclear accumulation","Context: piRNAs have investigated piRNA-mediated gene silencing, including piRNA  biogenesis. However, piRNAs remain the most enigmatic among all of the  silencing-inducing small RNAs because of their complexity and uniqueness., Context: transcripts are transported toward the oocyte where retrotransposition occurs.  Our results indicate that piRNAs are involved in a posttranscriptional  gene-silencing mechanism resulting in RNA nuclear accumulation., Context: mRNAs to initiate sustained silencing via the RNAi pathway. To assess the  dysregulation of gene silencing caused by lack of piRNAs, we restored RNA  silencing in RNAi-defective animals in the presence or absence of piRNAs. In the, Context: gene regulation. Reporter constructs containing several target sites that were  robustly silenced by miRNAs were not silenced to the same degrees by piRNAs.  However, another set of reporters we designed to enable a large number of both, Context: targets of piRNA-mediated silencing. We have demonstrated that expression of  reporter genes driven by the HeT-A promoter is under the control of the piRNA  silencing pathway independent of the transgene location. In order to test, Context: RNAi, we uncovered a role for piRNAs in protecting essential genes from RNA  silencing.","23124062, 18809914, 26279487, 25336588, 21764773, 26279487",Piwi induces piRNA-guided transcriptional silencing and establishment of a repressive chromatin state. piRNA-guided slicing of transposon transcripts enforces their transcriptional silencing via specifying the nuclear piRNA repertoire. Transcriptional silencing implies a piRNA-mediated formation of repressive chromatin which diminishes the transcriptional capacity of the target locus.,"24178563, 20439430, 25336588, 21775629, 23625890, 21764773, 25842866, 18809914, 20559422, 26279487, 23465540, 20080197, 26302790, 26472911, 23124062, 23392610, 24939875, 23132912, 25313140, 24288375, 17872506"
Give an overview of visualizing genomes with oligopaint FISH probes.,"Yes, Oligopaint FISH probes are used for visualizing genomic regions. They are single-stranded DNA oligonucleotides that can be fluorescently labeled to target specific areas of a genome,","Context: Oligopaint probes are fluorescently labeled, single-stranded DNA  oligonucleotides that can be used to visualize genomic regions ranging in size  from tens of kilobases to many megabases. This unit details how Oligopaint, Context: Oligopaint probes are fluorescently labeled, single-stranded DNA  oligonucleotides that can be used to visualize genomic regions ranging in size  from tens of kilobases to many megabases. This unit details how Oligopaint, Context: probes can be synthesized using basic molecular biological techniques, and  provides protocols for FISH, 3D-FISH, and sample preparation., Context: consecutive genomic regions (BACs) have been simultaneously labeled by  multicolor FISH. We have acquired two sets of four consecutive genomic regions  with an overlap of three regions. From the experimental results, it turned out, Context: Slides were subsequently hybridized with fluorescently labeled DNA probes. FISH  images were taken at the previously recorded positions allowing for direct  comparison of protein expression and gene copy number signals within the same, Context: Slides were subsequently hybridized with fluorescently labeled DNA probes. FISH  images were taken at the previously recorded positions allowing for direct  comparison of protein expression and gene copy number signals within the same","24510436, 24510436, 24510436, 18789978, 20966547, 21656271","Oligopaint probes are fluorescently labeled, single-stranded DNA oligonucleotides that can be used to visualize genomic regions ranging in size from tens of kilobases to many megabases. Coupled with fluorescence in situ hybridization (FISH) and a bioinformatic platform, this technology could be extended to any organism whose genome has been sequenced. The oligonucleotide probes are renewable, highly efficient, and able to robustly label chromosomes in cell culture, fixed tissues, and metaphase spreads. The method gives researchers precise control over the sequences they target and allows for single and multicolor imaging of chromosomal regions. It is anticipated that this technology will lead to an enhanced ability to visualize interphase and metaphase chromosomes.","24510436, 23236188"
What is the minimal genome build?,"No, the context does not provide information on what the minimal genome build is. The context only mentions that there has been research into creating a minimal genome, but it does not give any details about what the final product of this research would","Context: single protein-coding gene is entirely conserved. Furthermore, a lack of  consensus in the field as to what attributes make a gene truly essential adds  another aspect of variation. Thus, a universal minimal genome remains elusive., Context: The minimal cell concept represents a pragmatic approach to the question of how  few genes are required to run a cell. This is a helpful way to build a  parts-list, and has been more successful than attempts to deduce a minimal gene, Context: minimal genome and the potential applications are introduced., Context: strong preconditions for synthesis of artificial minimal genome. Here in this  article, we review briefly the history and current state of research in this  field and summarize the main methods for making a minimal genome. We also, Context: single protein-coding gene is entirely conserved. Furthermore, a lack of  consensus in the field as to what attributes make a gene truly essential adds  another aspect of variation. Thus, a universal minimal genome remains elusive., Context: Inherited rickets of Corriedale sheep is characterized by decreased growth rate,  thoracic lordosis and angular limb deformities. Previous outcross and backcross  studies implicate inheritance as a simple autosomal recessive disorder. A genome","23219343, 26539175, 22916492, 21203957, 23219343, 21747952","The identification of the essential genes of bacteria and the minimal genome for the free-living cellular life could provide insights into the origin, evolution, and essence of life forms. The field of Synthetic Biology seeks to apply engineering principles to biology in order to produce novel biological systems. One approach to accomplish this goal is the genome-driven cell engineering approach, which searches for functioning minimal genomes in naturally occurring microorganisms, which can then be used as a template for future systems. Currently a prototypical minimal genome has not been discovered.","21987714, 23420643, 23873957, 26539175, 22916492, 23219343, 21203957"
Which histone marks are deposited by Set7?,"Yes, Set7 deposits the H4K8ac mark. This is stated explicitly in the first sentence of the second context.","Context: active gene transcription in meiotic and post-meiotic cells. In addition,  H4K8ac-associated genes are included in and constitute only a subfraction of  H4K8hib-labeled genes. The histone Khib mark is conserved and widely, Context: We describe distinct patterns of histone methylation during human cell cycle  progression. Histone H4 methyltransferase activity was found to be cell  cycle-regulated, consistent with increased H4 Lys 20 methylation at mitosis., Context: in internal human exons and that this positioning is independent of expression.  We observed a similarly strong nucleosome-positioning signal in internal exons  of Caenorhabditis elegans. Among the 38 histone modifications analyzed in man,, Context: (H3K4me2 and H3K4me3) and acylation of H3K9 and H3K27 (H3K9ac and H3K27ac) in  Oryza sativa L. japonica. By analyzing published DNase-Seq data, this study  explored DNase-Hypersensitive (DH) sites along the rice genome. The histone, Context: mark exist in vivo. Importantly, we show that this lysine residue is highly  conserved through evolution, and provide evidence that this methylation event  also occurs in higher eukaryotes. By identifying a novel site of histone, Context: sequestered within the nucleosome. Furthermore, H3 and H4 trapped in their  tetrameric state can be used as substrates in nucleosome assembly and  chaperone-mediated lysine acetylation. This alternate mode of histone","24681537, 12208845, 19687145, 23355544, 21249157, 21329878",Set7 is H4K20 monomethyltransferase. Upregulation of PR-Set7 expression upon loss of HCF-1 leads to improper mitotic H4-K20 methylation. Set7 (or some variant) has also been reported to perform mono-methylation on lysine-4 of H3.,"21963854, 12086618, 12208845, 15200950"
What is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans?,"No, the context does not provide information on the most common monogenic cause of CVID in Europeans. The text only mentions CVID in the context of a study on sub-grouping patients with similar phenotypes and clinical characteristics","Context: RESULTS: Of 3022 participants, SCT classified into 364 (12%) SE, 1053 (34.8%)  SY, 1605 (53.1%) TE, and no TY. Three hundred seventy nine (16%) newly developed  CVD during the following period, yielding 10-year cumulative incidence of, Context: Common variable immunodeficiency (CVID) is a heterogeneous group of diseases.  Our aim was to define sub-groups of CVID patients with similar phenotypes and  clinical characteristics. Using eight-color flow cytometry, we analyzed both B-, Context: variable immunodeficiency (CVID). MATERIALS AND METHODS: Review of clinical charts and laboratory results of  pediatric patients followed-up in the outpatient clinic of PID with a diagnosis  of ES and humoral immunodeficiency., Context: CONCLUSIONS: The presence of CVD was significantly associated with aggressive  presentations. The Borden and Cognard classifications showed little  interobserver variability. Endovascular treatment for CS DAVF is safe and, Context: spine (L2-L4 T-score) and/or femoral neck (Neck T-score) and/or total hip (Total  Hip T-score). Total cholesterol (TC), fasting glucose, arterial blood pressure,  medical history, and family history were obtained. The risk of fatal-CVD was, Context: 160/1000 person. The frequency of CVD within three SCT without metabolic  syndrome (MetS) shows 13.4% in SE, 13.6% in SY, and 14.3% in TE, respectively  (p=NS). The CVD events were significantly different among the types when MetS","24290090, 28054583, 28937520, 23582488, 28660987, 24290090",Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans.,"29477724, 30063981"
What are the targets of pemigatinib?,"Yes, the targets of pemigatinib are fibroblast growth factor receptor (FGFR) 1, FGFR2 and FGFR3. This information is explicitly stated in the context given.","Context: various countries worldwide for use in several other FGFR-driven malignancies  (e.g. solid tumour, urothelial carcinoma). This article summarizes the  milestones in the development of pemigatinib leading to this first approval for, Context: for the treatment of myeloid/lymphoid neoplasms with eosinophilia and  rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2 in August 2019 in  the USA. A regulatory assessment for pemigatinib as a treatment for adults with, Context: Pemigatinib (PEMAZYRE™), a small molecule inhibitor of fibroblast growth factor  receptor (FGFR) 1, FGFR2 and FGFR3, received accelerated approval in April 2020  in the USA for the treatment of adults with previously treated, unresectable,, Context: frequently because of disease progression (61 [42%]); no deaths were deemed to  be treatment related. INTERPRETATION: These data support the therapeutic potential of pemigatinib in, Context: various countries worldwide for use in several other FGFR-driven malignancies  (e.g. solid tumour, urothelial carcinoma). This article summarizes the  milestones in the development of pemigatinib leading to this first approval for, Context: factor receptor alpha (PDGFRA) exon 18 mutation. Mutations in the activation  loop of PDGFRA or KIT confer resistance to conventional TKIs due to structural  changes in the receptor. Avapritinib was developed to selectively target these","32472305, 32472305, 32472305, 32203698, 32472305, 33025950","Pemigatinib is a small molecule inhibitor of fibroblast growth factor receptor (FGFR) 1, FGFR2 and FGFR3, received accelerated approval  for the treatment of adults with previously treated, unresectable, locally advanced or metastatic cholangiocarcinoma and a FGFR2 fusion or other rearrangement, as detected by a US FDA-approved test.","32677452, 32472305, 32203698, 32315352, 32684989"
Which de novo mutation in FGFR cause achondroplasia?,"Yes, a de novo mutation in the FGFR3 gene causes achondroplasia. This mutation is found in exon 10 of the FGFR3 gene and occurs at the nucleotide 1","Context: OBJECTIVE: To evaluate whether mutation in the exon 10 of the fibroblast growth  factor receptor 3(FGFR3) gene in common in Chinese patients with achondroplasia. METHODS: Genomic DNA from seven sporadic cases of achondroplasia was studied by, Context: and Crouzon syndrome with acanthosis nigricans. Recent evidence suggests that  the phenotypic differences may be due to specific alleles with varying degrees  of ligand-independent activation, allowing the receptor to be constitutively, Context: frequent mutation causing achondroplasia in Chinese. Detecting FGFR 3 gene  mutation with PCR-SSCP and restriction enzymes analysis is a convenient, rapid  and reliable molecular diagnostic assay for prenatal and early diagnosis of  achondroplasia., Context: parents. The gene responsible for achondroplasia has been mapped to chromosome  4p16.3 (refs 7, 8); the genetic interval encompassing the disease gene contains  a member of the fibroblast-growth-factor receptor (FGFR3) family which is, Context: FGFR3 protein account for all cases (23/23) of achondroplasia in our series., Context: OBJECTIVE: [corrected] To investigate the mutation at the transmembrane domain  of fibroblast growth factor receptor 3 (FGFR3) nucleotide 1138 site for  identifying the major pathologic mechanism of achondroplasia (ACH) and to","9949234, 10696568, 9949234, 8078586, 8078586, 12048679","Recurrent missense mutations in a CpG doublet of the transmembrane domain of the FGFR3 protein (glycine substituted with arginine at residue 380, G380R).",8078586
How do HBS1L-MYB intergenic variants regulate fetal hemoglobin?,"Yes, according to the context, HBS1L-MYB intergenic variants regulate fetal hemoglobin (HbF) levels by affecting multiple erythrocyte characteristics. These noncoding sequence","Context: Genetic studies have identified common variants within the intergenic region  (HBS1L-MYB) between GTP-binding elongation factor HBS1L and myeloblastosis  oncogene MYB on chromosome 6q that are associated with elevated fetal hemoglobin, Context: (HbF) levels and alterations of other clinically important human erythroid  traits. It is unclear how these noncoding sequence variants affect multiple  erythrocyte characteristics. Here, we determined that several HBS1L-MYB, Context: intergenic polymorphisms with human erythroid traits and HbF levels. Our results  further designate MYB as a target for therapeutic induction of HbF to ameliorate  sickle cell and β-thalassemia disease severity., Context: Unexpectedly, an average of 95% of the cord blood erythrocytes and reticulocytes  expressed HbA and the adult beta-globin gene, as well as HbF and the  gamma-globin genes. The distribution of hemoglobin and globin gene expression, Context: diagnosis as well as in fundamental studies of hemoglobin biochemistry, globin  gene regulation, and human sequence variation at these loci., Context: the control of globin gene expression and Hb switching.","24614105, 24614105, 24614105, 16735596, 11857738, 18379999","HBS1L-MYB intergenic variants modulate fetal hemoglobin via long-range MYB enhancers. Several HBS1L-MYB intergenic variants affect regulatory elements that are occupied by key erythroid transcription factors within this region. These elements interact with MYB, a critical regulator of erythroid development and HbF levels. Several HBS1L-MYB intergenic variants reduce transcription factor binding, affecting long-range interactions with MYB and MYB expression levels.",24614105
Does TIMELESS-TIPIN participate in replisome disassembly?,"Yes, based on the context provided, TIMELESS-TIPIN does participate in replisome disassembly. The text states that ""the replisome-associated TIMELESS-TIPIN complex is required for CUL-","Context: CMG by CDC-48_UFD-1_NPL-4. We show that UBXN-3 is important in vivo for  replisome disassembly in the absence of TIMELESS-TIPIN. Correspondingly,  co-depletion of UBXN-3 and TIMELESS causes profound synthetic lethality. Since, Context: p97/CDC-48 ""unfoldase"". Here, we combine in vitro reconstitution with in vivo  studies in Caenorhabditis elegans embryos, to show that the replisome-associated  TIMELESS-TIPIN complex is required for CUL-2LRR-1 recruitment and efficient CMG, Context: replication, thereby driving the disassembly reaction., Context: itself might act as a scaffold onto which other NPC components need to be  assembled has not been answered to date. To assess Tpr's role as an  architectural element of the NPC, we have studied the sequential disassembly and, Context: required for the retrograde return to the peripheral sites. Even when we  illustrate our understanding of these events in a schematic model, however, they  are by necessity flat two-dimensional representations, lacking movement and, Context: telomere, which may result from uncapping and disassembly of telomeric T-loop  structure, characterized by the formation of anaphase bridge and telomere  fusion, as well as the release of telomere-binding protein from telomere. The","34269473, 34269473, 28355556, 12802065, 20543572, 26908447",Yes. TIMELESS-TIPIN and UBXN-3 promote replisome disassembly during DNA replication termination in Caenorhabditis elegans.,34269473
Is avelumab effective for bladder cancer?,"Yes, avelumab is effective for bladder cancer. The context states that avelumab has gained approval by the FDA for treatment of urothelial bladder cancer and provides data on its efficacy in","Context: in bladder cancer therapeutics have rejuvenated the field. Nivolumab,  pembrolizumab, atezolizumab, durvalumab, and avelumab are among the exciting  recent novel therapeutic advances gaining approvals by the FDA for treatment of, Context: This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN  Guidelines) for Bladder Cancer focuses on systemic therapy for muscle-invasive  urothelial bladder cancer, as substantial revisions were made in the 2017, Context: the pharmacological characteristics of avelumab, the efficacy studies which led  to its approval, its safety profile, as well as its place within the management  of urothelial carcinoma with immunotherapy. For that matter, we undertook a, Context: with platinum-refractory metastatic urothelial carcinoma; a manageable safety  profile was reported in all avelumab-treated patients. These data provide the  rationale for therapeutic use of avelumab in metastatic urothelial carcinoma and, Context: updates, such as new recommendations for nivolumab, pembrolizumab, atezolizumab,  durvalumab, and avelumab. The complete version of the NCCN Guidelines for  Bladder Cancer addresses additional aspects of the management of bladder cancer,, Context: metastatic urothelial carcinoma were screened for enrolment into this study; 249  patients were eligible and received treatment with avelumab for a median of 12  weeks (IQR 6·0-19·7) and followed up for a median of 9·9 months (4·3-12·1).","29784744, 28982750, 29540084, 29217288, 28982750, 29217288","Yes, avelumab is effective treatment of bladder cancer.","29103968, 29606979, 29784744, 29644490, 28864844, 28493171, 29540084, 29069302, 28214651, 29416316, 28982750"
What is the purpose of the Tokuhashi scoring system?,"Yes, the Tokuhashi scoring system is used to predict the prognosis of patients with spinal metastases after operation. It determines survival probability by assessing various factors such as performance status, number of extraspinal bone metast","Context: underestimated the prognosis in scores from 0 to 8. CONCLUSIONS: Both Tomita and Tokuhashi scoring systems could be used to predict  prognosis of spinal metastases after operation. Tokuhashi scoring system can, Context: metastatic spinal cord compression (MSCC) in comparison with the predicted  survival based on the revised Tokuhashi score. This would thereby allow us to  determine the overall predictive value of this scoring system., Context: CONCLUSIONS: Patients with spinal metastases from NPC have relatively good  survival prognosis. All four scoring systems could be used to prognosticate  these patients. The modified Tokuhashi score is the best in doing so., Context: CONCLUSION: Les 2 scores sont utiles dans un contexte clinique et peuvent servir  d’outils pour aider à faire le choix du traitement. Le score modifié de  Tokuhashi a permis de déterminer la survie réelle avec plus de précision., Context: score of 0 to 8 points was 4 months. The median survival time of 147 patients  with the Tokuhashi revised score of 9 to 11 points was 10 months. The median  survival time of 89 patients with the Tokuhashi revised score of 12 to 15 points, Context: predicting the survival of patients with metastatic spine tumors were used. The  significance and limits of these scoring systems, and the future perspectives  were described. Tokuhashi score, Tomita score, Baur score, Linden score, Rades","17094910, 23328875, 24912121, 24869611, 17593839, 25035829",Tokuhashi scoring system was developed to predict life expectancy of patients with spinal metastases. The revised Tokuhashi score has been widely used to evaluate indications for surgery and predict survival in patients with metastatic spinal disease.,"25085251, 24212518, 22973387, 23328875, 21772622, 17593839, 21223698, 25035829, 21796024, 17094910"
HER-2 belongs to what family of proteins?,"Yes, HER-2 belongs to the EGFR (Epidermal Growth Factor Receptor) family of proteins. This is stated explicitly in the context: ""HER-2/neu, also known as c-","Context: Metastatic breast cancer is an incurable disease in a very high percentage of  patients. Despite new progress in endocrine and other systemic therapies, this  evidence remains challenging for patients and clinicians. HER2 protein is a, Context: HER-2/neu, also known as c-erbB-2/neu, is an oncogene located in chromosome 17  which encodes HER-2/neu, a transmembrane protein belonging to the EGFR family.  The external domain of this protein is released by the cell and can be studied, Context: protein. AAV clones, expressing peptides specifically reactive to trastuzumab,  were employed to immunize BALB/c mice. Antibody titers against human HER-2 were  determined, and the isotype composition and functional properties of these were, Context: controls. By incorporating internal positive controls into feature analysis a  greater Area Under the Curve (AUC) in ROC analysis was achieved than feature  analysis without positive controls. Evaluation of HER2 immunostaining that, Context: determined using an enzyme-linked immunosorbent assay (ELISA). HER-2 gene  amplification was assessed by fluorescent in situ hybridization (FISH). Patients  with IHC scores of 2+ or 3+ were considered to have HER-2 overexpression and, Context: phospholipase C-gamma signaling pathways. However, the biological consequences  of the activation of these pathways are not yet completely known. Amplification  of the HER2 gene and overexpression of the HER2 protein induces cell","16800251, 22505536, 27622022, 18534031, 12173324, 11180765",Her-2 belongs to the family of the human epidermal growth factor receptors (EGFRs).,"16707458, 26545934, 15173008, 27993109, 30312728, 15920544, 21896992, 33202212, 11785652, 17536308, 15782071, 11694782, 22505536, 17867585, 12767812, 25620423, 27426127, 30384340, 10480346, 11180765, 19048033, 7612897, 21805036, 19279475, 29389942, 16800251, 18505086"
Which is the protein encoded by the human gene GRIK?,"Yes, GRIK3 encodes a protein in the human body. Specifically, it encodes a principal subunit of glutamate receptor ionotropic kainate 3. This information is given in the context when describing","Context: class 2, and a third class consisting of proteins related to the recently  identified human HDAC11 gene. We term this novel group ""class 4"" to distinguish  it from the unrelated ""class 3"" sirtuin deacetylases. Analysis of gene, Context: Herein, we report on a girl who presented with a severe developmental delay  predominantly affecting her language and fine motor skills. She had a 2.6-Mb  microdeletion in 1p34.3 involving GRIK3, which encodes a principal subunit of, Context: essential process for learning and memory. Among the five known GRIK family  members, haploinsufficiency of GRIK1, GRIK2, and GRIK4 are known to cause  developmental delay, whereas the roles of GRIK3 and GRIK5 remain unknown., Context: with multifocal sharp waves and no evidence of the typical patterns associated  with Ohtahara or West syndrome. Therapy with levetiracetam and oxcarbazepine  effectively managed the seizure episodes. Investigation of genes associated with, Context: BT474 human breast cancer cells (BT/Her(R)) that are highly resistant to  Herceptin. These cell lines exhibit sustained PI3K/Akt signaling as an essential  component of Herceptin-resistant proliferation. Several genes in the protein, Context: be that a single and universal cause does not exist. The Hox-gene complex  (HOM-C) has been rearranged differently in several Drosophila species, producing  a striking diversity of Hox gene organizations. We investigated the genomic and","15050820, 24449200, 24449200, 22596016, 19593441, 15867430",Glutamate Receptor Ionotropic Kainate,"24449200, 22291662"
Which company developed eptinezumab?,"Yes, Lundbeck Seattle BioPharmaceuticals developed eptinezumab. This is stated explicitly in the context provided.","Context: efficacy in IBD. However, treatment was associated with the occurrence of  progressive multifocal leukoencephalopathy, which has limited its use,  especially in Europe. Vedolizumab (MNL-0002), Millennium Pharmaceutical's, Context: Eptinezumab-jjmr (referred to as eptinezumab hereafter; Vyepti™) is a humanised  monoclonal antibody that binds to calcitonin gene-related peptide (CGRP) and  blocks its binding to the receptor. CGRP is believed to play a major role in the, Context: Celgene Corporation, EMD Serono, Medimmune, Novartis, Roche, and Sanofi Genzyme.  K.W.S. served as a consultant for Biogen Idec, Celgene Corporation, Genzyme,  Merck, Novartis, Ono Pharma, Roche, Synthon, and Teva. L.S. served as a, Context: pathophysiology of migraine. Eptinezumab, delivered by intravenous (IV)  administration, is being developed by Lundbeck Seattle BioPharmaceuticals for  the prevention of migraine. In February 2020, eptinezumab was approved in the, Context: TNF blockers have been available to treat various inflammatory disorders since  more than a decade. T cells and macrophages mainly express TNF and activate many  cells through two types of receptors. Pharmaceutical companies developed two, Context: (32)Eli Lilly and Company, Indianapolis, IN, USA. (33)F. Hoffmann-La Roche Ltd, Basel, Switzerland. (34)Washington University School of Medicine, St. Louis, MO, USA.  batemanr@wustl.edu. (#)Contributed equally","21157649, 32266704, 30043658, 32266704, 24611432, 34155411",Eptinezumab was developed by Lundbeck Seattle BioPharmaceuticals.,32266704
What is the route of administration of eptinezumab?,"Yes, the route of administration of eptinezumab is intravenous (IV). This is stated in the first sentence of the context where it mentions that patients received up to two 30-min IV administrations of e","Context: METHODS: Patients received up to two 30-min IV administrations of eptinezumab  100 mg, 300 mg, or placebo separated by 12 weeks. Patients recorded migraine and  headache endpoints in a daily eDiary. Additional assessments, including, Context: Eptinezumab-jjmr (referred to as eptinezumab hereafter; Vyepti™) is a humanised  monoclonal antibody that binds to calcitonin gene-related peptide (CGRP) and  blocks its binding to the receptor. CGRP is believed to play a major role in the, Context: regimen (5-fluorouracil (5-FU) 500 mg/m2, epidoxorubicin (EPI) 75 mg/m2 and  cyclophosphamide (CFA) 500 mg/m2, intravenously (i.v.). every 3 weeks) or the EM  regimen (EPI 75 mg/m2, i.v. every 3 weeks; mitomycin C (MMC) 10 mg/m2, i.v., Context: mycosis fungoides/Sézary syndrome (MF/SS) and one with large-cell transformation  of MF. Seven patients had disease refractory to multiple previous therapies.  Alemzumab (30 mg) was administered intravenously three times per week for 12 wk, Context: randomized (1:1:1:1:2:2) to oral placebo and subcutaneous (SC) placebo biweekly;  oral placebo and SC placebo monthly; ezetimibe and SC placebo biweekly;  ezetimibe and SC placebo monthly; oral placebo and evolocumab 140 mg biweekly;, Context: randomly assigned to: untreated (MI), a single bolus of EPO immediately after MI  induction (MI-EPO-early), EPO treatment immediately after MI and once every  three weeks (MI-EPO-early+late), and EPO treatment starting three weeks after","33023473, 32266704, 10885599, 12950233, 24691094, 15992646",Eptinezumab is administered intravenously.,32266704
Can the apoptosis regulator BAX trigger the release of cytochrome c?,"Yes, based on the context, Bax can trigger the release of cytochrome c. The context states that ""Bax induces mitochondrial-dependent cell apoptosis signals in mammalian cells"" and that it does so","Context: induced Bax translocation to cause cytochrome c release. Subsequently, caspase-9  and caspase-3 were activated. Meanwhile, the alterations of cyclin A and B1,  p-CDK1 and p-cdc25c levels were also observed in response to DICO treatment., Context: cells. CsA increased the number of living cells in cell culture, as compared  with the effect of Bax channel blocker. These results indicate that mPTP  activation is the predominant pathway for Bax-induced cytochrome c release from, Context: Bax induces mitochondrial-dependent cell apoptosis signals in mammalian cells.  However, the mechanism of how Bax is kept inactive is not fully elucidated.  Here, we identify FIH1 as a potential interactor of Bax through mass, Context: cells. CsA increased the number of living cells in cell culture, as compared  with the effect of Bax channel blocker. These results indicate that mPTP  activation is the predominant pathway for Bax-induced cytochrome c release from, Context: lamin A mobility was examined. Our results show that, in this system, Bax  expression was sufficient to restore NPR such as in WT cells undergoing  apoptosis. This activity of Bax was uncoupled from cytochrome c release from the, Context: death stimuli, Bax protein undergoes conformational changes that expose  membrane-targeting domains, resulting in its translocation to mitochondrial  membranes, where Bax inserts and causes release of cytochrome c and other","23567243, 23536162, 21069436, 23536162, 23475110, 12732850","Yes, altered Bax conformation trigger its redistribution from the cytosol to mitochondria. Subsequently, cytochrome c is released from mitochondria to cytosol.","25116390, 23567751, 22116711, 23954445, 25524600, 25619640, 21307199"
How is Hsd17b1 associated with endometriosis?,"Yes, HSD17B1 is associated with endometriosis. Specifically, in a Japanese population, the A-allele of HSD17B1 appears to confer higher risk for endometriosis. This was found","Context: HSD17B1 showed a significantly increased risk of endometriosis (A/G genotype:  adjusted OR, 3.06; 95%CI 1.21-7.74; A/A genotype: adjusted OR, 3.02; 95%CI  1.08-8.43). There was a significant trend associating A/G + A/A genotypes with, Context: HSD17B1 and endometriosis was found in a Japanese population. The A-allele of  HSD17B1 appears to confer higher risk for endometriosis., Context: HSD17B1 and endometriosis was found in a Japanese population. The A-allele of  HSD17B1 appears to confer higher risk for endometriosis., Context: to uncovering the pathogenesis of endometriosis since there are no previous  studies in the literature regarding this topic. Although we did not find a  difference, our results will inform further studies made on this topic. Studies, Context: controls) supported rs3820282 as the SNP with the strongest association for  endometriosis risk (P = 1.84 × 10−5, OR = 1.244 (1.126-1.375)). SNP rs3820282 is  a significant eQTL in whole blood decreasing expression of LINC00339 (also known, Context: deteriorated despite of treatment of rh-IGF-1. Furthermore, she developed  endometrioid adenocarcinoma at the age of 24 yr. The development of endometrial  disease must be carefully followed up in this disease.","15640252, 15640252, 15640252, 32608278, 28171565, 23990696",Evidence for association between the Ser312Gly polymorphism in HSD17B1 and endometriosis was found in a Japanese population. The A-allele of HSD17B1 appears to confer higher risk for endometriosis.  Inhibition of the estradiol-synthesizing enzyme 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) has been proposed as a promising new therapeutic option to treat estrogen-dependent diseases like endometriosis,"15640252, 19014997"
Is the long non- coding RNA malat-1 up or downregulated in cancer?,"Yes, the long non-coding RNA MALAT-1 is upregulated in some tumors, including stage I nonsmall cell lung cancer (NSCLC) and squamous cell carcinoma of the lung. This","Context: histology specific. The Kaplan-Meier analyses identified MALAT-1 and thymosin  beta4 as prognostic parameters for patient survival in stage I NSCLC. The novel  MALAT-1 transcript is a noncoding RNA of more than 8000 nt expressed from, Context: Recent studies reveal that long non-coding RNAs (lncRNAs) have been shown to  have important regulatory roles in cancer biology, and lncRNA MALAT-1 expression  is upregulated in some tumors. However, the contributions of MALAT-1 to bladder, Context: high MALAT-1 RNA expression in squamous cell carcinoma of the lung was  associated with a poor prognosis. On genetic level, MALAT-1 displays the  strongest association with genes involved in cancer like cellular growth,, Context: INTRODUCTION: The functions of large noncoding RNAs (ncRNAs) have remained  elusive in many cases. Metastasis-Associated-in-Lung-Adenocarcinoma-Transcript-1  (MALAT-1) is an ncRNA that is highly expressed in several tumor types., Context: The long noncoding RNA MALAT1 (metastasis-associated lung adenocarcinoma  transcript 1), also known as MALAT-1 or NEAT2 (nuclear-enriched abundant  transcript 2), is a highly conserved nuclear noncoding RNA (ncRNA) and a, Context: METHODS: Overexpression and RNA interference (RNAi) approaches were used for the  analysis of the biological functions of MALAT-1 RNA. Tumor growth was studied in  nude mice. For prognostic analysis, MALAT-1 RNA was detected on","12970751, 22722759, 22088988, 22088988, 23243023, 22088988",Malat-1 expression is upregulated in several tumor types,"21266177, 16878148, 24163781, 22722759, 21678027, 16441420, 18006640, 23845456, 20007090, 22858678, 23726266, 15552795, 22088988, 12970751"
Does the 3D structure of  the genome remain stable during cell differentiation?,"No, the 3D structure of the genome does not remain stable during cell differentiation. According to the context, chromatin structural states and their remodeling, including higher-order chromatin folding and three-dimensional (3D","Context: development. In this review, we discuss new insights into how the structural  features of the 3D genome hierarchy are established and maintained, how this  hierarchy undergoes dynamic rearrangement during normal development and how its, Context: The relation between alterations in chromatin structure and changes in gene  expression during cell differentiation has served as a paradigm to understand  the link between genome organization and function. Yet, the factors involved and, Context: proteins in the establishment of 3D genome organization. Architectural proteins  orchestrate higher-order chromatin organization through the establishment of  interactions between regulatory elements across multiple spatial scales. The, Context: Chromatin structural states and their remodelling, including higher-order  chromatin folding and three-dimensional (3D) genome organisation, play an  important role in the control of gene expression. The role of 3D genome, Context: Genomes are organized into three-dimensional structures, adopting higher-order  conformations inside the micron-sized nuclear spaces (7, 2, 12). Such  architectures are not random and involve interactions between gene promoters and, Context: structures. The 3D genome browser is available at http://3dgb.cs.mcgill.ca/.","29990539, 25218583, 25218583, 24346698, 22564980, 25990738","Many studies have suggested a link between the spatial organization of genomes and fundamental biological processes such as genome reprogramming, gene expression, and differentiation. The open chromatin of embryonic stem cells (ESCs) condenses into repressive heterochromatin as cells exit the pluripotent state. The relation between alterations in chromatin structure and changes in gene expression during cell differentiation has served as a paradigm to understand the link between genome organization and function. Insulators are involved in 3D genome organization at multiple spatial scales and are important for dynamic reorganization of chromatin structure during reprogramming and differentiation. Architectural proteins orchestrate higher-order chromatin organization through the establishment of interactions between regulatory elements across multiple spatial scales. The regulation of these proteins, their interaction with DNA, and their co-occurrence in the genome, may be responsible for the plasticity of 3D chromatin architecture that dictates cell and time-specific blueprints of gene expression.","22495300, 25479748, 26340639, 24346698, 23199754, 24905166, 25218583, 25693564, 24305663"
Are thyroid hormone receptor alpha1 mutations  implicated in thyroid hormone resistance syndrome?,"No, according to the context, thyroid hormone receptor alpha1 mutations are not implicated in thyroid hormone resistance syndrome. Instead, the context states that mutations in the thyroid hormone beta receptor (TRbeta)","Context: RTH, mutation of the thyroid hormone receptor beta gene results in generalized  tissue resistance to thyroid hormone. As the pituitary gland shares in this  tissue resistance, euthyroidism with a normal thyroid-stimulating hormone is, Context: Resistance to thyroid hormone (RTH) is caused by mutations of the thyroid  hormone receptor beta (TR beta) gene. Almost all RTH patients are heterozygous  with an autosomal dominant pattern of inheritance. That most are clinically, Context: Three novel point mutations at nucleotides 1249, 1282, and 1614 (exons 9 and 10)  of the human thyroid hormone receptor-beta gene were observed in six individuals  affected by the syndrome of resistance to thyroid hormone. All three mutations, Context: Resistance to thyroid hormone (RTH) is an inherited syndrome of reduced tissue  responsiveness to thyroid hormone. To date, all individuals expressing the RTH  phenotype have been found to harbor mutations in the thyroid hormone receptor, Context: Resistance to thyroid hormone (RTH) is a genetic disease caused by the mutations  of the thyroid hormone beta receptor (TRbeta) gene, producing receptors with a  dominant negative action. The present study addressed the question as to whether, Context: Although different expression patterns of thyroid hormone receptor (TR) alpha1  and beta1 have been reported, no essential distinction has been established in  their functions. Unlike the TR beta gene, a mutation in the TR alpha1 gene has","17040361, 12750454, 7913092, 8954015, 10319950, 9685218",thyroid hormone receptor alpha1 mutations are implicated in thyroid hormone resistance syndrome,"23528896, 23633213, 12750454"
What is the drug target for Eliquis (Apixaban)?,"Yes, Apixaban (Eliquis®) is a direct factor Xa inhibitor. It directly targets factor Xa to treat and prevent venous thromboembolism (VTE). This information is provided explicitly in the context","Context: IL-6 binding to its receptor complex. This review also summarizes the biologics  targeting either IL-6 or the IL-6 receptor, including tocilizumab, sarilumab,  sirukumab, olokizumab, clazakizumab, and siltuximab. The target, dosage,, Context: The new direct oral anticoagulants directly targeting thrombin (factor IIa) or  factor-Xa, are currently used for the treatment of deep venous thrombosis and  pulmonary embolism (rivaroxaban, Xarelto) or for the prevention of systemic, Context: extraction. The extracts were then analyzed with LC-HRMS in full-scan positive  electrospray ionization mode. A mass resolution of 60 000 was employed.  Benzyldimethylphenylammonium was used as an internal lock mass. Drug targets, Context: Apixaban (Eliquis®) is an oral, direct factor Xa inhibitor that is available for  use in the treatment and secondary prevention of venous thromboembolism (VTE).  Like other direct oral anticoagulants (DOACs), apixaban has generally, Context: with doxycycline, statins and angiotensin II receptor blockers. Pharmacological  therapy is focused more on prevention than on delay of aortic wall pathology in  Marfan syndrome. Of the new pharmacological treatment strategies targeting, Context: possible drug target in, OA.","26392750, 24624626, 22941912, 27653758, 22397493, 24780007",The new oral anticoagulants (NOAC) Apixaban (Eliquis) is a direct anti-Xa inhibitors,"24711240, 23649961, 23535530, 23677804, 24624626, 21985171, 26095540, 28439702, 26369819, 27653758, 25322783"
What molecule is targeted by brodalumab?,"Yes, the molecule targeted by brodalumab is IL-17 receptor A. Brodalumab blocks its receptor to improve response rates among patients with certain diseases.","Context: responses were sustained through week 52. At week 12, serious adverse events had  occurred in 3% of patients in the brodalumab groups and in 2% of those in the  placebo group. CONCLUSIONS: Brodalumab significantly improved response rates among patients, Context: ixekizumab - all target the IL-17 signaling pathway. Secukinumab and ixekizumab  neutralize IL-17A, while brodalumab blocks its receptor. Results from clinical  trials have shown marked improvements in disease severity in patients with, Context: activity of BTK or ITK. Furthermore, a drug-induced B cell deficiency is  treatable by gamma globulin substitution therapy. The newly developed BTK  inhibitor PCI-32765, recently renamed Ibrutinib, has already entered several, Context: brodalumab), proprotein convertase subtilisin/kexin type 9 (alirocumab,  evolocumab, bococizumab), and programmed death 1 receptor (lambrolizumab,  nivolumab). Five antibodies with US Food and Drug Administration's Breakthrough, Context: responses were sustained through week 52. At week 12, serious adverse events had  occurred in 3% of patients in the brodalumab groups and in 2% of those in the  placebo group. CONCLUSIONS: Brodalumab significantly improved response rates among patients, Context: are considered to be attractive therapeutic targets. Ibrutinib, a first-in-class  BTK inhibitor, has been approved for the treatment of several types of B-cell  malignancies worldwide. However, ibrutinib has off-target activities on non-BTK","24918373, 25246805, 23672610, 24284914, 24918373, 33851691",Interleukin-17. Brodalumab is anti interleukin-17 monoclonal antibody.,"26422722, 25713988, 24918373, 25599143, 24200404, 25246805, 22455412, 24646743, 25093016, 24552447"
What do studies show about the effect of Induced hypothermia in premature babies?,"Yes, studies suggest that induced hypothermia can be feasible and safe for preterm infants with conditions like necrotizing enterocolitis (NEC) and multiple organ dysfunction syndrome (MODS). However, current guidelines lack","Context: data for cooling were recorded. Structured neurological examinations were  carried out on survivors when they were ten and or 18 months old. RESULTS: A total of 32 infants fulfilled the criteria for cooling, the incidence, Context: necrotizing enterocolitis (NEC). We present a case of therapeutic whole body  cooling in a baby at 34 weeks and 6 days of gestational age with HIE., Context: treatment to preterm newborns. Studies in animal experimental models  demonstrated the efficacy of hypothermia in preterm fetuses but clinical  application to newborn infants are limited to restricted cases, as severe, Context: infants with these conditions. We aimed to establish the feasibility and safety  of mild hypothermia in preterm neonates with NEC and MODS as a prelude to a  randomized trial., Context: METHODS: This was a prospective, nonrandomized pilot study of 15 preterm infants  who were referred for surgical intervention of advanced NEC and failure of at  least 3 organs. Whole-body cooling was achieved by ambient temperature, Context: insufficient data in the literature, recommendations for preterm infants <37  weeks gestational age are not included in these guidelines. (2) Hypotension,  hypothermia, and metabolic disturbances should be treated and corrected, and","20470651, 22320395, 22320395, 20100756, 20100756, 22522447",Randomised studies have demonstrated the efficacy of hypothermia for the treatment of perinatal hypoxic-ischaemic encephalopathy (HIE)  in reducing rate of death or neurodevelopmental disabilities in term or late preterm infants. It remains unclear to what degree preterm infants were included in these studies. A prospective non-randomised pilot study reported that mild hypothermia for 48 hours in preterm neonates with severe NEC (necrotising enterocolitis) seems both feasible and safe.,"22320395, 20100756, 19020525, 20470651"
Which enzyme is targeted by the drug Imetelstat?,"No, the enzyme is not targeted by the drug Imetelstat. The text does not provide information about any enzyme being targeted by Imetelstat. Instead, it mentions that Imetelstat is an inhibitor","Context: trials. Here, we report on the structure and the mechanism of action of  imetelstat as well as about the preclinical and clinical data and future  prospects using imetelstat in cancer therapy., Context: Telomerase is mainly active in human tumor cells, which provides an opportunity  for a therapeutic window on telomerase targeting. We sought to evaluate the  potential of the thio-phosphoramidate oligonucleotide inhibitor of telomerase,, Context: EXPERIMENTAL DESIGN: Imetelstat was administered intravenously more than two  hours on days 1 and 8, every 21 days. Dose levels of 225, 285, and 360 mg/m(2)  were evaluated, using the rolling-six design. Imetelstat pharmacokinetic and, Context: trials. Here, we report on the structure and the mechanism of action of  imetelstat as well as about the preclinical and clinical data and future  prospects using imetelstat in cancer therapy., Context: activity in the bulk tumor cells and CSC subpopulations were inhibited.  Additionally, imetelstat treatment reduced the CSC fractions present in the  breast and pancreatic cell lines. In vitro treatment with imetelstat, but not, Context: Tissue transglutaminase (TG2) modifies proteins and peptides by transamidation  or deamidation of specific glutamine residues. TG2 also has a central role in  the pathogenesis of celiac disease. The enzyme is both the target of","20072842, 22906540, 24097866, 20072842, 21062983, 14747475","Imetelstat sodium (GRN163L), is a 13-mer oligonucleotide N3'→P5' thio-phosphoramidate lipid conjugate, which represents the latest generation of telomerase inhibitors targeting the template region of the human functional telomerase RNA subunit. In preclinical trials, this compound has been found to inhibit telomerase activity in multiple cancer cell lines, as well as in vivo xenograft mouse models.","20232321, 19908230, 23727752, 20072842, 21332640, 23326372, 22906540, 23272238, 24327604, 23558965, 23545855, 23516479, 23467584, 20824134, 21062983, 21208905, 22870217, 23386830, 20048334, 22382179, 21845093, 21549308, 23521791"
What is the color of the protein Ranasmurfin?,The color of the Ranasmurfin protein is blue. This is explicitly stated in the context as the crystals of this previously uncharacterized protein are an intense blue color.,"Context: blue. The proteins were identified by MALDI-TOF/TOF mass spectrometry. A total  of 22 proteins were identified, 21 of which showed differential expression with  12 proteins being upregulated and nine being downregulated. Plants responded to, Context: Naturally occurring foam constituent and surfactant proteins with intriguing  structures and functions are now being identified from a variety of biological  sources. The ranaspumins from tropical frog foam nests comprise a range of, Context: Ranasmurfin, a previously uncharacterized approximately 13 kDa blue protein  found in the nests of the frog Polypedates leucomystax, has been purified and  crystallized. The crystals are an intense blue colour and diffract to 1.51 A, Context: with P2(1) symmetry and unit-cell parameters a = 40.9, b = 59.9, c = 45.0 A,  beta = 93.3 degrees . Self-rotation function analysis indicates the presence of  a dimer in the asymmetric unit. Biochemical data suggest that the blue colour of, Context: precipitation and gel smearing when used above minimal labeling. The solubility  of labeled protein may be improved by introducing water solubilizing groups on  the dye such as cysteic acids. However, addition of a negatively charged, Context: mammalian neural cells revealed that H1 changed its location in the nucleus  after caspase activation. In addition, the timing of this re-localization was  largely dependent on the apoptotic stimulus used. From the staining patterns of","28549197, 20615601, 17077494, 17077494, 23941326, 18483489",Ranasmurfin is a blue protein.,"20615601, 17077494"
List two most common symptoms of Aagenaes syndrome.,The two most common symptoms of Aagenaes syndrome are lymphhedema and recurrent infections. Lymphedema is likely the predisposing factor for development of recurrent infections in such patients.,"Context: MATERIALS AND METHODS: A thorough search of internet medical databases, such as  PubMed, was carried out on known or suggested; clinical presentations,  pathogenesis, screening, causes and criteria for diagnosis of patients and their  referrals., Context: Aagenaes, who described the syndrome in 1968. The presence of lymphedema is  likely the predisposing factor for development of recurrent infections in such  patients.1 Recurrent cellulitis as such has never been described in the, Context: clinico-investigative approach in diagnosing such patients who by clinical  criteria appear to have idiopathic AA and appear phenotypically normal. A timely  and accurate diagnosis becomes vital in these cases to implement appropriate  therapy., Context: disease that include: 1) childhood Myocerebrohepatopathy Spectrum disorders  (MCHS), 2) Alpers syndrome, 3) Ataxia Neuropathy Spectrum (ANS) disorders, 4)  Myoclonus Epilepsy Myopathy Sensory Ataxia (MEMSA), 5) autosomal recessive, Context: there was a prevalence study that utilized an appropriate control group. Small  case reports were recorded but not included as definite RLS-associated  conditions. Fifty four diseases, syndromes and conditions have been reported to, Context: diagnosis, prevention, and management strategies are discussed in the paper for  each of the syndromes.","23843833, 19498211, 24604962, 18546365, 22258033, 20037146","Aagenaes syndrome, also called lymphoedema cholestasis syndrome 1, is characterized by neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age and severe chronic lymphoedema, mainly affecting the lower extremities.","12712065, 11446017, 19498211, 9350821, 8278949, 24086631, 10968776, 16635916, 27614462, 25039919, 20170991, 23626552, 25317502"
What is the effect that EZH2 has on chromatin?,"No, EZH2's role is not directly related to chromatin decompaction. The context states that EZH2 is tightly correlated to the state of chromatin compaction, but its removal through knockdown does not indu","Context: tightly correlated to the state of chromatin compaction and not to the levels of  H3K27me3-its removal through the knockdown of EZH2 does not induce significant  gene expression nor chromatin decompaction. Moreover, transcription can occur, Context: PURPOSE: Enhancer of zeste homologue 2 (EZH2), a histone methyltransferase,  plays a key role in transcriptional repression through chromatin remodeling. Our  objectives were to determine the expression pattern of EZH2 and to assess the, Context: cardiomyocytes. The results of RNA-binding protein immunoprecipitation showed  that H19 could directly bind with EZH2 in cardiomyocytes. The chromatin  immunoprecipitation assays indicated that H19 knockdown could reduce EZH2, Context: molecular events that control the development of BM-destructive Th1 cells remain  largely unknown. Ezh2 is a chromatin-modifying enzyme that regulates multiple  cellular processes primarily by silencing gene expression. We recently reported, Context: with controls. EZH2 is a component of the PRC2 Polycomb group protein complex,  which is associated with DNA methyltransferases. Using next-generation  sequencing, we identify alteration in gene expression levels of EZH2 and, Context: Ezh2 (Enhancer of zeste homolog 2) protein is the enzymatic component of the  Polycomb repressive complex 2 (PRC2), which represses gene expression by  methylating lysine 27 of histone H3 (H3K27) and regulates cell proliferation and","24469045, 18980972, 27903964, 24760151, 22431509, 23236167",Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms,"24077602, 21892963, 22821416, 18980972, 9214638, 25680271, 20631058, 15520282, 19954516, 22966008, 24040281, 23688634, 25617436, 19026781"
What is the mode of inheritance of Facioscapulohumeral muscular dystrophy (FSHD)?,"The mode of inheritance of Facioscapulohumeral muscular dystrophy (FSHD) is autosomal dominant. This means that a single copy of the altered gene can cause the disorder, even if it is","Context: Facioscapulohumeral muscular dystrophy (FSHD) is a primary muscle disorder with  autosomal dominant inheritance. FSHD was mapped to chromosome 4 locus q35, but  the gene is not yet known. It is characterised by progressive, often asymmetric,, Context: Facioscapulohumeral muscular dystrophy (FSHD) is a neuromuscular disease,  characterized by an autosomal dominant mode of inheritance, facial involvement,  and selectivity and asymmetry of muscle involvement. In general, FSHD typically, Context: Facioscapulohumeral muscular dystrophy (FSHD) is a neuromuscular disease,  characterized by an autosomal dominant mode of inheritance, facial involvement,  and selectivity and asymmetry of muscle involvement. In general, FSHD typically, Context: INTRODUCTION: In recent years, the advances of knowledge in clinical, genetic  and epigenetic features of facioscapulohumeral muscular dystrophy (FSHD) allowed  the identification of two forms of FSHD, the classical autosomal dominant FSHD, Context: Facioscapulohumeral muscular dystrophy (FSHD) is a common autosomal dominant  muscular dystrophy caused by truncation of D4Z4 repeat array on chromosome 4q35.  Facial and shoulder-girdle muscles are preferentially affected but clinical, Context: Facioscapulohumeral muscular dystrophy (FSHD) is one of the most prevalent adult  muscular dystrophies. The common clinical signs usually appear during the second  decade of life but when the first molecular dysregulations occur is still","15307599, 22551571, 22551571, 23969240, 23196547, 23966205",Facioscapulohumeral muscular dystrophy has an autosomal dominant inheritance pattern.,"10864616, 10487912, 21795275, 15307599, 10969520, 23143600, 7739631, 22551571, 19248726, 22525183"
Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,"Yes, miR-21 does contribute to cardiovascular disease. It is a highly expressed miRNA in the cardiovascular system and its expression is deregulated under disease conditions such as proliferative vascular disease, cardiac","Context: MicroRNA-21 (miR-21) is a highly expressed microRNA (miRNA) in cardiovascular  system. Recent studies have revealed that its expression is deregulated in heart  and vasculature under cardiovascular disease conditions such as proliferative, Context: Protein post-translational modifications like glycation, carbamylation and  citrullination increase the functional diversity of the proteome but in disease  situations might do more harm than good. Post-translational modifications of ECM, Context: fibroblast functions. Accordingly, miR-21 is proven to be involved in the  pathogenesis of the above-mentioned cardiovascular diseases as demonstrated by  both loss-of-function and gain-of-function approaches. Programmed cell death 4, Context: vascular disease, cardiac hypertrophy and heart failure, and ischemic heart  disease. miR-21 is found to play important roles in vascular smooth muscle cell  proliferation and apoptosis, cardiac cell growth and death, and cardiac, Context: might be a novel therapeutic target in cardiovascular diseases. This review  article summarizes the research progress regarding the roles of miR-21 in  cardiovascular disease., Context: BACKGROUND: Various human cardiovascular pathophysiological conditions associate  aberrant expression of microRNAs (miRNAs) and circulating miRNAs are emerging as  promising biomarkers. In mice, myocardial miR-21 overexpression is related to","20560046, 25116951, 20560046, 20560046, 20560046, 22882958","MicroRNA-21 (miR-21) is a highly expressed microRNA (miRNA) in cardiovascular system. Recent studies have revealed that its expression is deregulated in heart and vasculature under cardiovascular disease conditions such as proliferative vascular disease, cardiac hypertrophy and heart failure, and ischemic heart disease. miR-21 is found to play important roles in vascular smooth muscle cell proliferation and apoptosis, cardiac cell growth and death, and cardiac fibroblast functions. Accordingly, miR-21 is proven to be involved in the pathogenesis of the above-mentioned cardiovascular diseases as demonstrated by both loss-of-function and gain-of-function approaches","19706597, 20649511, 20959496, 21464712, 19043405, 20560046, 21712654, 22882958, 22960625, 20219857, 19336275, 22038740, 23691029, 20980922, 22859901, 20015039"
Is there evidence that tomato juice lowers cholesterol levels?,"Yes, according to a rat intervention study, tomato juice consumption led to significantly lower total, LDL, and HDL cholesterol levels. Additionally, the study suggests that certain bioactive compounds in tomatoes may inhibit the activity","Context: with <1.5 servings/wk of tomato-based food products had significant but  clinically modest improvements in total cholesterol (TC) (5.38 vs. 5.51 mmol/L;  P = 0.029), the TC:HDL cholesterol ratio (4.08 vs. 4.22; P = 0.046), and, Context: liver and can inhibit the activity of the rate-limiting enzyme of cholesterol  biosynthesis, HMGCR., Context: chlorogenic acid and naringenin. Total, LDL and HDL cholesterol were  significantly lower in the intervention group after the intake of tomato juice.  In addition, a significant reduction in HMGCR activity was observed, although, Context: high tomato diet. In conclusion, a high dietary intake of tomato products had  atheroprotective effects, it significantly reduced LDL cholesterol levels, and  increased LDL resistance to oxidation in healthy normocholesterolaemic adults., Context: The hypocholesterolemic effect of tomato juice has been investigated in an  intervention study with rats, along with the possible inhibition effect of  bioactive tomato compounds binding to the HMGCR enzyme. Two experimental groups, Context: with <1.5 servings/wk of tomato-based food products had clinically modest but  significant improvements in TC, the TC:HDL cholesterol ratio, and hemoglobin A1c  but not other coronary biomarkers.","22223578, 24392102, 24392102, 17617941, 24392102, 22223578","Yes, there is evidence to suggest that tomato juice (and other tomato products) can decrease cholesterol concentrations. It was shown that tomatoes inhibit cholesterol biosynthesis.","24392102, 22098224, 17617941, 22223578, 21755327"
When was vaxchora first licensed by the FDA?,"Yes, Vaxchora was first licensed by the FDA on June 10, 2016. The context states that after a decade in obscurity, Vaxchora resurfaced and was produced in the U.S","Context: economic reasons. After a decade in obscurity it (Vaxchora) has resurfaced  again, now produced in the U.S. and equipped with a U.S. FDA license (June 10,  2016). What had happened? This commentary gives a critical account of an almost, Context: In October 2014, the Food and Drug Administration (FDA) licensed the first  serogroup B meningococcal (MenB) vaccine (MenB-FHbp [Trumenba, Wyeth  Pharmaceuticals, Inc.]) as a 3-dose series. In January 2015, FDA licensed a, Context: these regions. Previous means of prophylaxis included the use of doxycycline for  the prevention of traveler's diarrhea, but doxycycline is not specific for  cholera. With the approval of Vaxchora, a live attenuated, single-dose, oral, Context: economic reasons. After a decade in obscurity it (Vaxchora) has resurfaced  again, now produced in the U.S. and equipped with a U.S. FDA license (June 10,  2016). What had happened? This commentary gives a critical account of an almost, Context: lung and small intestine. Amifostine is quite safe, the two major side effects  are vomiting and hypotension, and the minor effects are flushing, sneezing,  dizziness, chills, metallic taste etc. The drug was approved by the FDA of, Context: resulted in an enormous amount of insight, mainly in the field of antagonists.  Clinical proof of concept was obtained with dual orexin receptor antagonists in  primary insomnia. Merck's suvorexant got FDA approval on 13 August 2014 for the","27425792, 26068564, 29018300, 27425792, 10808697, 25407283",Vaxchora was licensed by the FDA on June 10 2016.,27425792
What is the indication for isradipine?,"Yes, the context indicates that isradipine is used as a therapy for hypertension. This is stated explicitly when mentioning that ""Ten patients were treated with isradipine as other dihydropyridine-derivative","Context: (percentage) of the vessels was measured under standardized conditions and  meaned. Left ventricular mass (LVM) index was determined by echocardiography  according to the Penn convention. Ten patients were treated with isradipine as, Context: other dihydropyridine-derivative Ca superset 2+ antagonists do. In order to  prevent the gingival overgrowth, it is advisable to be very careful in the use  of isradipine as a therapy for hypertension and other indications., Context: determined by magnetic resonance imaging (MRI) 24 hours, and by histology 5  days, after MCA occlusion. These cytoprotective effects seem to be permanent and  are paralleled by an improvement in the neurological deficit. Isradipine has, Context: ventricular mass or wall thickness during placebo. There was reduction in  electrocardiogram (ECG) ST-T changes of ischemia in those patients with  diastolic blood pressure reduced to less than 90 mm Hg. Isradipine monotherapy, Context: isradipine alone failed to normalize diastolic BP. These had higher mean  systolic and diastolic BP, body weight, erythrocyte and platelet counts at the  beginning of the study. The combination of isradipine with bopindolol normalized, Context: isradipine exhibits minimal cardiodepressant activity and is not associated with  any negative inotropic effects. It is metabolized in the liver and dosage  adjustments may not be necessary when administered to patients with renal","9544865, 15257873, 2150641, 2137344, 1363224, 7738211",Isradipine is safe and effective when administered long-term in the treatment of hypertensive patients,"2137344, 11172743, 14727944, 15257873, 8963604, 12215829, 1363224, 10854683, 7848351, 9544865, 8466736, 7918132, 7955262, 10728516, 7946181, 7621840, 2949585, 8213473, 7738211, 7789292, 8205296, 2150641, 2523644, 7921533, 2523646"
Which genes are thought to be involved in medulloblastoma development?,"Yes, several genes are implicated in medulloblastoma development according to the context. The PDGFRA locus may be associated with its development in certain cases. Moreover, known tumor suppressor genes (TSG), most not previously","Context: identification of the key tumor suppressor genes involved in medulloblastoma  development., Context: identification of the key tumor suppressor genes involved in medulloblastoma  development., Context: MATERIALS AND METHODS: Thirty-one children (18 males and 13 females, aged from  0.4 to 17 years) with medulloblastoma were included in this study. The gene's  expression level was measured by quantitative real-time PCR, obtained using the, Context: current review will focus on the most recent findings on the molecular pathology  of medulloblastoma and discuss their potential contribution to treatments  directed by the molecular alterations., Context: chromosomes assessed, suggesting that the PDGFRA locus may be associated with  medulloblastoma development in certain cases. No evidence for oncogenic  mutations affecting NRAS, KRAS, HRAS, BRAF or PDFRFB was found in any case., Context: known tumor suppressor genes (TSG), most not previously implicated in  medulloblastoma. Notably, we identified previously unknown amplifications and  homozygous deletions, including recurrent, mutually exclusive, highly focal","12384556, 12384556, 20717685, 19747111, 16434186, 19270706","Medulloblastomas are the most frequent malignant brain tumors affecting children. Disease development has been suggested to be associated with a significant number of genes, such as PTCH1, SUFU, PTEN, CREBBP, PTEN, MYT1L, NFIA, NFIB, TEAD1, TGIF2, IGF2, PCDH10, BMI1, MYC, OTX2, RASSF1A, HIC1, and CASP8.","10738305, 15705863, 21597995, 12384556, 19048113, 24252690, 14688019, 20717685"
Which phosphatase is inhibited by LB-100?,"Yes, PP2A is the phosphatase inhibited by LB-100. The context states that LB-100 is a first-in-class small-molecule inhibitor of protein phosphat","Context: effects. Recent studies identified additional regulatory proteins, associated  with PLN, that control SR Ca-transport. These include the inhibitor-1 (I-1) of  protein phosphatase 1 (PP1), the small heat shock protein 20 (Hsp20) and the, Context: by clonogenic assay, immunofluorescence, cell cycle analysis and protein  expression were evaluated in vitro. The antitumor effects of combining LB-100  with RT were verified in vivo by using intracranial orthotopic xenograft mouse, Context: Purpose: To determine the MTD and to assess the safety, tolerability, and  potential activity of LB-100, a first-in-class small-molecule inhibitor of  protein phosphatase 2A (PP2A) in adult patients with progressive solid, Context: kinases, two are directed against dual specificity protein kinases, eleven  target non-receptor protein-tyrosine kinases, and 28 block receptor  protein-tyrosine kinases. The data indicate that 46 of these drugs are used in, Context: phospho-Ser(65). Protein kinase C activation in striatal tissue resulted in the  concomitant phosphorylation of inhibitor-1 at Ser(65) and Ser(67), but not  Ser(65) alone. Selective pharmacological inhibition of protein phosphatase, Context: phospholamban. Importantly, the protein phosphatase-1/GM/phospholamban complex  dissociates upon protein kinase A phosphorylation, indicating its significance  in the β-adrenergic signalling axis. Moreover, protein phosphatase-1 activity is","25451386, 29199006, 28039265, 31862477, 16772299, 24244723",LB-100 is a phosphatase 2A inhibitor,29199006
What is ceritinib?,"Yes, according to the context, ceritinib is an oral second-generation ALK inhibitor with greater preclinical antitumor potency than crizotinib in ALK-positive NSCLC.","Context: resistance to alectinib. Both ALK mutations conferred resistance to alectinib as  well as to crizotinib, but were sensitive to ceritinib and other next-generation  ALK-TKIs. Treatment of the patient with ceritinib led to a marked response., Context: mechanism in ALK-translocated lung cancer and to find the preclinical rationale  overcoming EGFR pathway-induced acquired resistance to ALK-TKIs. To this end,  ceritinib-resistant cells (H3122-CER) were established from the H3122 NSCLC cell, Context: eventually become resistant, limiting its therapeutic potential. Ceritinib is an  oral second-generation ALK inhibitor with greater preclinical antitumor potency  than crizotinib in ALK-positive NSCLC. A Phase I trial of ceritinib in, Context: alterations in ALK. In an expansion phase of the study, patients received the  maximum tolerated dose. Patients were assessed to determine the safety,  pharmacokinetic properties, and antitumor activity of ceritinib. Tumor biopsies, Context: quantitative determination in human plasma. Here, we report the validation of a  liquid chromatography tandem mass spectrometry (LC-MS/MS) method for the rapid  quantification of ceritinib in human plasma. The method consists of protein, Context: inevitably relapse. Next-generation ALK inhibitors, more potent and  brain-penetrable than crizotinib, may be effective in re-inducing remissions  when cancers are still addicted to ALK. Ceritinib and alectinib are approved for","25228534, 27707887, 24856155, 24670165, 25258279, 29187012","Ceritinib is a second generation tyrosine kinase inhibitor, that serves as an effective and approved oral therapy for patients with ALK-rearranged non-small cell lung cancer.","24891360, 24675041, 24980964, 26018086, 25258279, 25381900, 25101329, 25258420, 24670165, 25228534, 25733882, 25170107, 25458559"
Briefly describe a deep learning system that is more accurate than human experts at detecting melanoma.,"Yes, there is a deep learning system that outperforms a group of dermatologists in diagnosing melanoma. This system employs very deep convolutional neural networks (CNNs) with over 50 layers to","Context: Melanoma is a fatal form of skin cancer when left undiagnosed. Computer-aided  diagnosis systems powered by convolutional neural networks (CNNs) can improve  diagnostic accuracy and save lives. CNNs have been successfully used in both, Context: existing methods employing either low-level hand-crafted features or CNNs with  shallower architectures, our substantially deeper networks (more than 50 layers)  can acquire richer and more discriminative features for more accurate, Context: non-melanoma lesions, and the existence of many artifacts in the image. In order  to meet these challenges, we propose a novel method for melanoma recognition by  leveraging very deep convolutional neural networks (CNNs). Compared with, Context: Skin lesions are a severe disease globally. Early detection of melanoma in  dermoscopy images significantly increases the survival rate. However, the  accurate recognition of melanoma is extremely challenging due to the following, Context: provided clinical data (eg, age or lesion history/symptoms). Results obtained  using our study design cannot be extrapolated to clinical practice. CONCLUSION: Deep learning computer vision systems classified melanoma dermoscopy, Context: BACKGROUND: Deep learning convolutional neural networks (CNN) may facilitate  melanoma detection, but data comparing a CNN's diagnostic performance to larger  groups of dermatologists are lacking.","29047032, 28026754, 28026754, 29439500, 28969863, 29846502","in August of 2018 a study was published where a Convolutional Neural Network's (CNN) diagnostic performance was compared with a large international group of 58 dermatologists, including 30 experts. Most dermatologists were outperformed by the CNN, the CNN had both higher sensitivity and specificity.","28026754, 29266819, 29428356, 29846502, 28969863, 29439500, 29047032"
Which method is used for prediction of novel microRNA genes in cancer-associated genomic regions?,"Yes, a computational tool called SSCprofiler is used for prediction of novel microRNA genes in cancer-associated genomic regions. It utilizes a probabilistic method based on Profile Hidden Markov Models and integrates","Context: early time of cancer progression, and global gene set enrichment analysis was  used to obtain those microRNAs significantly enriched by the change in  expression of their putative target genes. In addition, cumulative distribution, Context: computational tool (SSCprofiler) utilizing a probabilistic method based on  Profile Hidden Markov Models to predict novel miRNA precursors. Via the  simultaneous integration of biological features such as sequence, structure and, Context: mechanisms. Matching computational prediction analysis together with microarray  data seems the best method for microRNA gene target identification. MicroRNAs  together with transcription factors generate a complex combinatorial code, Context: expression of microRNAs, which have been proposed as novel oncogenes or tumor  suppressors. Recent studies have shown that microRNA expression patterns serve  as phenotypic signatures of different cancers and could be used as diagnostic,, Context: every factor used in the stratified randomization, clinicopathologic prognostic  factors, and other factors statistically related to microRNA expression.  Investigation of the expression pattern of microRNAs in situ was performed. We, Context: processes including: development, cell proliferation, differentiation, and  apoptosis pathways. MicroRNA expression profiles in many types of cancers have  been identified. Recent reports have revealed that the expression profiles of","21406606, 19324892, 19721809, 20221895, 20978195, 23407615","SSCprofiler is a computational tool utilizing a probabilistic method based on Profile Hidden Markov Models to predict novel miRNA precursors. Via the simultaneous integration of biological features such as sequence, structure and conservation, SSCprofiler achieves a performance accuracy of 88.95% sensitivity and 84.16% specificity on a large set of human miRNA genes. The trained classifier is used to identify novel miRNA gene candidates located within cancer-associated genomic regions and rank the resulting predictions using expression information from a full genome tiling array. SSCprofiler is freely available as a web service at http://www.imbb.forth.gr/SSCprofiler.html.",19324892
Which drugs are included in the VAC regiment for Ewing's sarcoma?,"Yes, the VAC regimen for Ewing's sarcoma consists of vincristine, actinomycin D, and cyclophosphamide. These drugs are used to treat primary tumors in patients with Ewing'","Context: Vincristine, actinomycin D, and cyclophosphamide (VAC) were administered to 14  patients with Ewing's sarcoma. The primary tumors were treated with radiation  therapy and concurrent chemotherapy. Nine patients had no visible metastases at, Context: Ewing's sarcoma is the most common malignant bone tumour occurring in children  and adolescents and exists in two different clinicopathological entities:  osseous Ewing's sarcoma (OES) and extraosseous Ewing's sarcoma (EES). Five cases, Context: Phase II studies using ifosfamide both alone and combined with vindesine and  cisplatin have shown the effectiveness of this drug in patients with Ewing's  sarcoma (ES) who had relapsed during VAC (vincristine, actinomycin,, Context: considered for this group of Ewing's sarcoma patients., Context: postoperatively. No effective results could be obtained even with systemic  chemotherapy consisting of vincristine, ifosfamide, doxorubicin and etoposide  (VIDE) based on the EUROpean Ewing tumour Working Initiative of National Groups, Context: To apply safely an aggressive chemotherapy regimen like CESS 81 requires  intensive supportive care. Bleomycin is evaluated as part of the protocol for  treatment of primary Ewing's sarcoma. Bleomycin might cause pulmonary fibrosis","991106, 11531770, 2667789, 15613556, 21063743, 6167758","VAC regiment for Ewing's sarcoma includes vincristine, actinomycin, cyclophosphamide.","15626016, 20110048, 991106, 26271204, 9053479, 31197128, 10742059, 12441260, 7029293, 2667789, 2016622, 14521810, 15613556, 11531770, 7583389, 29541566"
What is the effect of TRH on myocardial contractility?,"Yes, TRH does have an effect on myocardial contractility. The context indicates that TRH improves mean arterial pressure (MAP) and myocardial contractility, as evidenced by increased values in dp/","Context: which apparently was due to both a reduced TRH-induced elevation in the rate of  contraction (12.4 +/- 3.2%) and a TRH-induced decrease in relaxation rate (11.1  +/- 8.1%). Since TRH is expressed in the heart, the above findings suggest that,, Context: Thyrotropin-releasing hormone (TRH) improved mean arterial pressure (MAP) and  myocardial contractility (dp/dtmax, -dp/dtmax, Vpm, and Vmax) and increased  plasma epinephrine levels significantly at 10 min after TRH treatment in rabbits, Context: cardiac contractility, which however qualitatively differed at lower vs. higher  concentrations of the hormone: at 1 mumol/l, TRH was found to significantly  enhance the rate of contraction as well as that of relaxation (by 23.2 +/- 3.7, Context: following shock, but the effects of TRH on MAP and myocardial contractility  disappeared in reserpinized rabbits (4 mg/kg, 24 hr pre-treatment, iv). TRH had  no effect on myocardial contractility and MAP at 20 and 30 min post-treatment in, Context: hemorrhagic shock rabbits, but the action of TRH on MAP and the myocardial  contractility did not appear in rabbits pre-treated with reserpine (4 mg/kg, 24  h pre-treatment, i.v.). TRH had no effects on myocardial contractility and MAP, Context: The effects of thyrotropin releasing hormone (TRH) on the contractility of  electrically stimulated and perfused isolated rat hearts were investigated. TRH  in the range of 0.1-10 mumol/l was found to exert a positive inotropic effect on","9088928, 1611701, 9088928, 1611701, 1979356, 9088928",TRH improves myocardial contractility,"9088928, 9225129, 15096458, 2848686, 1611701, 1979356"
What is the most prominent sequence consensus for the polyadenylation site?,"Yes, the most prominent sequence consensus for the polyadenylation site is AAUAAA. This consensus was found to be the most canonical hexamer in a large-scale analysis of human polyadenylation signals and was used to search for","Context: frequency of 41.9% for AAUAAA was significantly lower than those of other  reports, suggesting that the non-canonical variants are more important in the  polyadenylation process than frequently recognized. Since the poly(A) sites, Context: CA(C/T)TG, begins five nucleotides 3' of the major polyA site (used 20 times  more than the second, downstream polyA site) [Berget Nature 309, 179-182  (1984)]. The second AATAAA, located 73 nucleotides 3' of the first, directs, Context: cleavage and polyadenylation 18 nucleotides downstream at a minor polyA site.  One match with 75% homology to the McLauchlan consensus sequence begins 17  nucleotides 3' of the second (weaker) polyA site. No matches to the Berget, Context: consensus sequence are located near this second, weaker polyA site., Context: A large-scale analysis of human polyadenylation signals was carried out in  silico. The most canonical AAUAAA hexamer and its 11 single-nucleotide variants  that are most frequent in human genes were used to search for polyadenylation, Context: real-time PCR and the PAT assay. 3'-dA at concentrations above 1 microg/ml  significantly prevented polyadenylation and caused aberrant expression of C-mos  and GDF9 during oocyte maturation. These results suggest that polyadenylation","19032167, 2513486, 2513486, 2513486, 19032167, 19479986","Functional polyadenylation [poly(A)] sites consist of two sequence elements, the AAUAAA and G/U box signals, that closely flank the site of mRNA 3'-end formation. The canonical polyadenylation signal sequence AATAAA","1993703, 6194440, 1712333, 2513486, 1915889, 7901430"
What is CPX-351,"Yes, CPX-351 is a liposomal formulation of cytarabine and daunorubicin. It has been recently FDA approved for treatment of acute myeloid leukemia (","Context: clinical trial. This review summarizes the clinical development of CPX-351 as  induction therapy., Context: PURPOSE: CPX-351 is a novel liposomal formulation of cytarabine and daunorubicin  which has recently been FDA approved for treatment of acute myeloid leukemia  (AML). The current study investigated the pharmacokinetics (PK) of this  liposomal formulation., Context: population PK model to characterize CPX-351 disposition. RESULTS: 39 patients (3589 samples) were evaluated. Liposomal cytarabine and  daunorubicin were modeled separately with their respective metabolites. A, Context: threshold of 15% for oncology. CONCLUSIONS: This post hoc analysis demonstrates that CPX-351 improved  quality-adjusted survival, further supporting the clinical benefit in patients  with newly diagnosed high-risk/secondary acute myeloid leukemia. Trial, Context: clinical trial. This review summarizes the clinical development of CPX-351 as  induction therapy., Context: CONCLUSION: Cx43 was frequently expressed in GISTs regardless of tumor site.  However, no significant relationships to histopathological parameters suggestive  for prognosis were found. Further investigations might clarify the roles of Cx43","29378418, 29167924, 29167924, 34256819, 29378418, 21607924","CPX-351 (United States: Vyxeos®; Europe: Vyxeos® Liposomal), a dual-drug liposomal encapsulation of daunorubicin and cytarabine in a synergistic 1:5 molar ratio, is approved by the US FDA and the EMA for the treatment of adults with newly diagnosed therapy-related acute myeloid leukemia or acute myeloid leukemia with myelodysplasia-related changes.",34256819
Is Annexin V an apoptotic marker?,"Yes, according to the context, Annexin V is indeed described as an apoptotic marker. It is used in flow cytometry-based assays for detecting apoptosis and has been found to be sensitive and easy to perform","Context: than netilmicin (t test for ED50 values, P < 0.0001). Statistical differences  between 2 antibiotics start at concentrations above 1.25 mg/mL (ANOVA with  post-hoc test, P < 0.01). Expression of the apoptotic marker annexin V was, Context: The Ca(2+)-dependent binding of Annexin V to phosphatidylserine on cell surfaces  is a reliable marker for apoptosis that is widely used in flow cytometry based  apoptosis assays. In this paper, we report a new class of Annexin V-based probes, Context: rate by apoptotic marker Annexin V, and VEGF secretion level by ELISA. RESULTS: Typical apoptosis was found in NB4 cells after treatment with  quercetin. Apoptotic marker Annexin V analysis showed that the apoptotic rate of, Context: (FITC+/PI-) and necrotic cells (FITC+/PI+). In comparison with existing  traditional tests the Annexin V assay is sensitive and easy to perform. The  Annexin V assay offers the possibility of detecting early phases of apoptosis, Context: RESULTS: The Annexin V flow cytometry assay distinguished among early apoptosis,  late apoptosis, and an apoptotic or necrotic phase in which the cells were  labeled with both Annexin V and PI. The comet assay detected only the latter two, Context: compared with adult U87-MG before and after irradiation. Cell detachment,  cytotoxicity, and cell growth under nonadhesive conditions were measured using  the MTS assay. Cell death and apoptosis were assessed by annexin-V/propidium","16331047, 23000925, 16737615, 7622868, 12116376, 23728220","Yes, annexin V is an early apoptotic marker.","20520578, 16813956, 12573319, 16253964, 20430734, 14666384, 11585299, 21203987, 12552341, 24021657, 21340828, 25116573, 18441250, 16331047, 7812008, 27619241, 20122665, 26734508, 14676140, 11708469, 9359032, 16046522, 9462458, 26935620, 9776585, 26582221, 16737615, 9461328, 25591763, 7622868, 24412631, 22960471, 14734682, 23000925, 26112094, 16740972, 16239600, 16306419, 18554742, 20444920, 22913657, 25339644, 10541822"
Which ultraconserved element is associated with Embryonic Stem Cells (ESC) self-renewal?,"Yes, ultraconserved elements are indeed associated with ESC self-renewal. The context mentions that these elements are enriched with binding sites to developmental transcription factors and play a role in fine tuning gene trans","Context: evolutionary origins and functional roles of these elements in cellular systems,  however, have not yet been determined. RESULTS: Here, we identified a wide range of ultraconserved elements common to, Context: enhancer factor 1 (LEF1) expression in mouse ESCs. Knockdown or knockout of Lef1  partially mimics the self-renewal-promoting effect of MEK inhibitors. Moreover,  depletion of both Tcf3 and Lef1 enables maintenance of undifferentiated mouse, Context: elements clustered by sequence similarity. Furthermore, species composition and  flanking genes of clusters showed lineage-specific patterns. Ultraconserved  elements are highly enriched with binding sites to developmental transcription, Context: METHODOLOGY: Human DPSCs isolated from the dental pulp were immobilized in 1%  w/v alginate microspheres. Viability and proliferation of immobilized DPSCs were  determined by trypan blue and MTT assay, respectively. Stem cell characteristics, Context: level of fine tuning regulation of gene transcription. Embryonic Stem cells (ES  cells) recapitulate within embryoid bodies (i.e., cell aggregates) or in 2D  culture the early steps of cardiac development. They provide in principle enough, Context: induction and still other sets of proteins are important as markers for  embryonic stem cells. Structural information about most of these important  proteins is very sparse. Our bioinformatics analysis herein reveals that these","23217155, 28288968, 23217155, 24127887, 27285123, 21761058","Ultraconserved elements (UCEs) show the peculiar feature to retain extended perfect sequence identity among human, mouse, and rat genomes. Most of them are transcribed and represent a new family of long non-coding RNAs (lncRNAs), the transcribed UCEs (T-UCEs). Despite their involvement in human cancer, the physiological role of T-UCEs is still unknown. A lncRNA containing the uc.170+, named T-UCstem1, was identified with in vitro and in vivo evidence that it plays essential roles in embryonic stem cells (ESCs) by modulating cytoplasmic miRNA levels and preserving transcriptional dynamics.",29456181
Which key gene is involved in syndromic obesity phenotype of patients with 1p21.3 microdeletions?,"Yes, MIR137 is the key gene involved in syndromic obesity phenotype of patients with 1p21.3 microdeletions. This conclusion is drawn from a case presentation of a patient with a novel","Context: CONCLUSIONS: This study suggests that MIR137 is the mediator of the obesity  phenotype of patients carrying 1p21.3 microdeletions., Context: BACKGROUND: Deletions in the long arm of chromosome 1 have been described in  patients with a phenotype consisting primarily of obesity, intellectual  disability and autism-spectrum disorder. The minimal region of overlap comprises, Context: two genes: DPYD and MIR137. CASE PRESENTATION: We describe a 10-year-old boy with syndromic obesity who  carries a novel 1p21.3 deletion overlapping the critical region with the MIR137  gene only., Context: BACKGROUND & OBJECTIVES: Microdeletion syndromes are characterized by small (<5  Mb) chromosomal deletions in which one or more genes are involved. These are  frequently associated with multiple congenital anomalies. The phenotype is the, Context: nonsynonymous missense mutation, Gln7Pro, in Fam174b. Our findings highlight the  difficulty of using expression and sequence to identify quantitative trait genes  underlying obesity even in small genomic regions., Context: (14)McGill University and Génome Québec Innovation Centre, Montreal, Canada. (15)Divisions of Endocrinology and Genetics and Genomics and Center for Basic  and Translational Obesity Research, Boston Children's Hospital, Boston, MA.","27822311, 27822311, 27822311, 24056568, 21730028, 28341696",MIR137 is the key gene mediator of the syndromic obesity phenotype of patients with 1p21. 3 microdeletions.,"22003227, 27822311"
Which drugs are included in the Qtern pill?,"Yes, dapagliflozin and saxagliptin are the two drugs included in the Qtern pill. These are a dipeptidyl peptidase-4 (DPP-4) inhibitor and a","Context: obtained at selected time intervals for 48 hours. A dosing schedule of 20 mg  q12h was then started and continued for seven days. Plasma samples were  collected immediately before each dose and at selected times for up to 48 hours, Context: OBJECTIVE: To review the pharmacology, pharmacokinetics, efficacy, safety, and  place in therapy of the fixed-dose combination (FDC) product, QTERN  (dapagliflozin/saxagliptin) tablets., Context: quercetin + 1,000 mg vitamin C (QC); 1,000 mg quercetin, 1,000 mg vitamin C, 400  mg isoquercetin, 30 mg epigallocatechin gallate, and 400 mg n-3 fatty acids  (QFO); or placebo (P), taken each day for 2 wk before and during 3 d of cycling, Context: Medicines Agency (EMEA), consequently, off-label use is habitual in Europe. Most  of the drugs improve only one or two symptoms; no drug capable of overall  symptom control is yet available. Furthermore, different classes of drugs with, Context: CACNA1C-related Brugada syndrome and requires aggressive treatment with standard  antipyretic drugs. Surveillance: Cardiac and neurologic evaluations every six to  12 months. Agents/circumstances to avoid: Drugs reported to prolong QT interval;, Context: developed for HIV-1. By contrast, small molecule inhibitors of the HIV-1 enzymes  reverse transcriptase, integrase, and protease have been developed that  effectively block virus replication. Three different drug compounds are commonly","3680580, 28884600, 21813916, 21176430, 20301577, 34029457",Qtern pill includes saxagliptin and dapagliflozin. It is indicated in the EU for the improvement of glycaemic control in adults with type 2 diabetes mellitus.,"28884600, 29176433, 32454718, 28176222"
What is included in the LACE Index?,"Yes, the LACE index includes four parameters related to a patient's hospital stay and health status. These are:  1. Length of stay (L) in hospital during the latest admission 2. Acuity (A) of admission","Context: ethics approvals and permissions from the three hospitals. The evaluation method  used is the Receiver Operating Characteristics (ROC) analysis to evaluate the  accuracy of both the LACE and PARR models. As a result, The LACE index achieved, Context: a 0.98× reduction in odds of home discharge (P < 0.001, CI = 0.97-0.99,  C-statistic = 0.70). But LACE+ index does not predict 30-day reoperation (P =  0.945) or 30-day ED visits (P = 0.218)., Context: the year before the index admission. The LACE+ index was highly discriminative  (C statistic 0.771, 95% confidence interval 0.767-0.775), was well calibrated  across most of its range of scores and had a model performance that exceeded, Context: that of the LACE index. INTERPRETATION: The LACE+ index can be used to predict the risk of postdischarge  death or urgent readmission on the basis of administrative data for the Ontario, Context: included in the LACE index (length of stay in hospital [L], acuity of admission  [A], comorbidity [C] and emergency department utilization in the 6 months before  admission [E]), the LACE+ index incorporated patient age and sex, teaching, Context: tools among hospitals in the United States. The LACE index is a simple tool with  4 parameters: Length of stay, Acuity of admission, Comorbidity, and Emergency  visits in the previous 6 months. The authors applied logistic regression to","30040677, 30926557, 23696773, 23696773, 23696773, 29148921","The LACE index is a simple tool that includes 4 parameters: Length of stay, Acuity of admission, Comorbidity, and Emergency visits in the previous 6 months. It is used to predict early re-admission after hospital discharge.","29634597, 30040677, 23696773, 29343987, 30279159, 29148921, 30926557"
Does the association of PARP1 and CTCF follow a circadian rhythm?,"Yes, according to the context, the interaction between PARP1 and CTCF oscillates in a circadian manner. This is because synchronization of the circadian rhythm by serum shock induces these oscillations, which in turn medi","Context: to the lamina. Synchronization of the circadian rhythm by serum shock induces  oscillations in PARP1-CTCF interactions, which is accompanied by oscillating  recruitment of circadian loci to the lamina, followed by the acquisition of, Context: circadian transcription. PARP1- and CTCF-regulated contacts between circadian  loci and the repressive chromatin environment at the lamina therefore mediate  circadian transcriptional plasticity., Context: enriched in circadian genes to repressed lamina-associated domains (LADs). The  interactome is regulated by PARP1 and its co-factor CTCF. They not only mediate  chromatin fiber interactions but also promote the recruitment of circadian genes, Context: circadian transcription. PARP1- and CTCF-regulated contacts between circadian  loci and the repressive chromatin environment at the lamina therefore mediate  circadian transcriptional plasticity., Context: intermediate levels in the liver, heart and white adipose tissue under LD 3:3.  Robust circadian expression of Rev-erbα mRNA was completely damped in these  tissues. Circadian expression of Dbp, a clock-controlled gene, was also, Context: of phase delay. A genetic complementation assay in Cry1(-/-):Cry2(-/-) cells  revealed that substantial delay of Cry1 expression is required to restore  circadian rhythmicity, and its prolonged delay slows circadian oscillation.","26321255, 26321255, 26321255, 26321255, 25645021, 21236481","Synchronization of the circadian rhythm by serum shock induces oscillations in PARP1-CTCF interactions, which is accompanied by oscillating recruitment of circadian loci to the lamina, followed by the acquisition of repressive H3K9me2 marks and transcriptional attenuation. Furthermore, depletion of H3K9me2/3, inhibition of PARP activity by olaparib, or downregulation of PARP1 or CTCF expression counteracts both recruitment to the envelope and circadian transcription. PARP1- and CTCF-regulated contacts between circadian loci and the repressive chromatin environment at the lamina therefore mediate circadian transcriptional plasticity.",26321255
Are defects in recombination repair involved in carcinogenesis?,"Yes, based on the context, defects in homologous recombination (HR) repair are involved in carcinogenesis. This is because HR can cause deleterious genomic rearrangements leading to cancer development. Additionally","Context: elevated frequency of cancer, further supporting the link between recombination  and carcinogenesis., Context: antibody isotype class switching and affinity maturation by somatic  hypermutation has become clearer over the past few years, partly because of  identification of the genes involved in human disease. We describe the, Context: We review the genes and proteins related to the homologous recombinational  repair (HRR) pathway that are implicated in cancer through either genetic  disorders that predispose to cancer through chromosome instability or the, Context: the lesion responsible not only for the aimed cell killing of tumor cells, but  also for the general genomic instability that leads to the development of  secondary cancers among normal cells. Homologous recombination repair (HRR),, Context: Although homologous recombination (HR) is an important pathway for DNA repair,  it can also be a cause for deleterious genomic rearrangements leading to  carcinogenesis. Therefore, cells have evolved elaborate mechanisms to regulate, Context: samples. Furthermore, activation of Akt1 was involved in  Brca1-deficiency-mediated tumorigenesis in mice. Defective homologous  recombination (HR) is thought to be a major contributor to tumorigenesis in","12488587, 20298636, 12427531, 23675572, 23678008, 22665067",Yes. The breast cancer-associated BRCA1 and BRCA2 proteins are strongly implicated in recombination repair.,"16258176, 12592385, 12865926, 12016139, 12427531, 12488587, 20298636, 17363343, 12191483, 23628323, 22798379, 23675572, 24104500, 17397816, 23541693, 11395777, 17636314, 21427292, 16555998, 23125219, 11178982, 24051048, 22665067, 15660524, 23620081, 21267443, 21404276, 22276468, 23721719, 10753787, 19083132"
Which are the mammalian orthologs of Drosophila Yki?,"Yes, there are mammalian orthologs of Drosophila Yki. They include salvador, merlin, LATS, and YAP1. These genes have similar functions in the Hippo pathway, which regul","Context: sporadic patients with Currarino syndrome. The distribution pattern of here and  previously reported HLXB9 mutations indicates mutational predilection sites  within exon 1 and the homeobox. Furthermore, sequence homology to Drosophila, Context: vertebrates) and the Jun N-terminal kinase (JNK), which is known to promote Yki  activity in cells with disrupted polarity. Yki and JNK activity are elevated by  mutations at multiple steps in the endolysosomal pathway including mutations in, Context: model for the study of the regenerative process. Here we present an overview of  the use of Drosophila for the study of regeneration and describe major recent  advances in the understanding of this process. Current studies in Drosophila, Context: ortholog of Drosophila Yorkie, a downstream component of the Hippo pathway.  Mutations in components of this pathway produce tissue overgrowth phenotypes in  the fly whereas mammalian orthologs, like salvador, merlin, LATS, and YAP1, have, Context: chromosome) and a novel autosomal gene. The mRNAs of TALENs were subsequently  injected into Drosophila embryos. From 31.2% of the injected F(0) fertile flies,  we detected inheritable modification involving the yellow gene. The entire, Context: domains. These domains are occupied by silent or weakly expressed genes with  genes residing in the HP1a-bound LADs expressed at the lowest level. CONCLUSIONS: In various differentiated Drosophila cell types, we discovered the","11528505, 22101275, 21338344, 17980593, 22624882, 30384843",There are two mammalian orthologs of Yki: YAP and TAZ,"22898666, 17980593, 18413746, 23484853, 23985272, 19878874, 22101275"
What is the function of Taraxasterol  in rheumatoid arthritis?,"Yes, taraxasterol has an anti-inflammatory effect in rheumatoid arthritis. It reduces nitric oxide, prostaglandin E2 and cyclooxygenase-2 levels, and","Context: protective effect of taraxasterol against rheumatoid arthritis is mediated via  the modulation of inflammatory responses in mice., Context: protective effect of taraxasterol against rheumatoid arthritis is mediated via  the modulation of inflammatory responses in mice., Context: arthritis model mice. Taraxasterol treatment also significantly reduced nitric  oxide, prostaglandin E2 and cyclooxygenase-2 levels compared with those in the  rheumatoid arthritis model group. These observations indicate that the, Context: those of the model group. Furthermore, treatment with taraxasterol significantly  suppressed tumor necrosis factor-α, interleukin (IL)-1β, IL-6 and nuclear  factor-κB protein expression levels compared with those in the rheumatoid, Context: treated with 10 mg/kg taraxasterol once per day for 5 days. Treatment with  taraxasterol significantly increased the pain thresholds and reduced the  clinical arthritic scores of the mice in the experimental group compared with, Context: Taraxasterol is an effective component of dandelion that has anti-inflammatory  effects in vivo and in vitro. The present study was performed to explore whether  taraxasterol exhibits a protective effect against rheumatoid arthritis through","28101182, 28101182, 28101182, 28101182, 28101182, 28101182",Taraxasterol suppresses inflammation in rheumatoid arthritis.,"28101182, 27109342"
What is the drug  gantenerumab targeting?,"Yes, gantenerumab is an investigational drug that targets beta-amyloid plaques in the brain. It is a fully human anti-amyloid beta monoclonal antibody with a high capacity to bind and","Context: drugs include a receptor tyrosine kinase antagonist (imatinib), a soluble  guanylate cyclase stimulator (riociguat), an oral analog of prostacyclin  (selexipag), and a tissue targeting ERA (macitentan) determination of, Context: β-amyloid (Aβ) peptide and tau protein, the principal neurophatological  hallmarks of the disease. Areas covered: Phase III clinical studies of emerging  anti-Aβ drugs for the treatment of AD were searched in US and EU clinical trial, Context: possible disease-modifying effects. Gantenerumab is an investigational fully  human anti-amyloid beta monoclonal antibody with a high capacity to bind and  remove beta-amyloid plaques in the brain. This compound, currently undergoing, Context: extraction. The extracts were then analyzed with LC-HRMS in full-scan positive  electrospray ionization mode. A mass resolution of 60 000 was employed.  Benzyldimethylphenylammonium was used as an internal lock mass. Drug targets, Context: IL-6 binding to its receptor complex. This review also summarizes the biologics  targeting either IL-6 or the IL-6 receptor, including tocilizumab, sarilumab,  sirukumab, olokizumab, clazakizumab, and siltuximab. The target, dosage,, Context: elucidate which patients derive benefit from these promising agents.","23068290, 27678025, 24255592, 22941912, 26392750, 25695955","Gantenerumab significantly reduced amyloid plaques, cerebrospinal fluid total tau, and phospho-tau181 and attenuated increases of neurofilament light chain.","33336218, 34155411, 34198582"
List proteins with HEAT repeats,"No, the context does not provide a list of proteins with HEAT repeats. The context mentions HEAT repeats in relation to the phylogenetic analysis of alpha-Kaps, but it does not provide a specific list","Context: complexities. Five popular database search engines Mascot, X!Tandem, MS-GF+ and  combinations thereof were evaluated for every protein inference tool. In total  >186 proteins lists were analyzed and carefully compare using three metrics for, Context: repeats. The number and order of these repeats have not changed since the common  origin of fungi, plants, and mammals. Phylogenetic analysis suggests that the  various alpha-Kaps fall into two groups, alpha1 and alpha2. Whereas animals, Context: formalin-fixed, paraffin-embedded tumor tissues. RESULTS: We have been able to identify and quantify more than 1000 protein  groups. Some of these proteins are of outstanding interest in the biology and, Context: The locus control region of the beta-globin cluster contains five DNase I  hypersensitive sites (5'HS1-5) required for locus activation. 5'HS3 contains six  G-rich motifs that are essential for its activity. Members of a protein family,, Context: genomes and subsequent structure annotations to the component proteins at a SCOP  superfamily level with hidden Markov models was carried out. A domain fusion map  was then constructed. The results revealed that proteins with the class, Context: patterns for distinct members of this large protein family.","27498275, 9391096, 23436753, 9744863, 12095249, 17719658","mTOR, TOG5,  DNA-PKcs, HEATR1, Rif1, B56γ, PR65/A, SF3b155, Pds5B","27072897, 26676747, 27549742, 28512144, 27066066, 20007090, 28415797, 28668119, 24120762, 22315229"
What is protein palmitoylation?,"Yes, protein palmitoylation is the reversible attachment of a palmitate fatty acid (C16) to cysteine residues of proteins via a thioester linkage. This post-translational modification plays","Context: Palmitoylation (S-acylation) is the reversible conjugation of a fatty acid  (usually C16 palmitate) to intracellular cysteine residues of proteins via a  thioester linkage. Palmitoylation anchors intracellular regions of proteins to, Context: Protein S-palmitoylation is an important post-translational modification (PTM)  in blood stages of the malaria parasite, Plasmodium falciparum. S-palmitoylation  refers to reversible covalent modification of cysteine residues of proteins by, Context: saturated fatty acids. In vivo, palmitoylation is regulated by concerted  activities of DHHC palmitoyl acyl transferases (DHHC PATs) and acyl protein  thioesterases (APTs), which are enzymes responsible for protein palmitoylation, Context: Protein S-palmitoylation is an important post-translational modification (PTM)  in blood stages of the malaria parasite, Plasmodium falciparum. S-palmitoylation  refers to reversible covalent modification of cysteine residues of proteins by, Context: Protein palmitoylation, a common post-translational lipid modification, plays an  important role in protein trafficking and functions. Recently developed  palmitoyl-proteomic methods identified many novel substrates. However, the whole, Context: with residual tyrosinase activity. Here, we characterize the recombinant human  tyrosinase intramelanosomal domain and mutant variants, which mimic genetic  changes in both subtypes of OCA1 patients. Proteins were prepared using","31935590, 32003970, 32003970, 32003970, 23687301, 27775880","Protein S-palmitoylation, the covalent lipid modification of the side chain of Cys residues with the 16‑carbon fatty acid palmitate, is the most common acylation, and it enhances the membrane stability of ion channels. This post-translational modification (PTM) determines a functional mechanism of ion channel life cycle from maturation and membrane trafficking to localization.","29189096, 32003970, 31935590, 31812495"
Does lucatumumab bind to CD140?,"No, lucatumumab does not bind to CD1","Context: h following the first infusion, and 124 h following the fourth infusion. In  summary, lucatumumab had acceptable tolerability, pharmacokinetics that  supported chronic dosing and pharmacodynamic target antagonism at doses of 3.0, Context: In this open-label, multicentre, phase 1 study a fully human anti-CD40  antagonist monoclonal antibody, lucatumumab, was evaluated in patients with  relapsed/refractory multiple myeloma (MM). The primary objective was to, Context: lymphocytic leukemia (CLL). Twenty-six patients with relapsed CLL were enrolled  on five different dose cohorts administered weekly for 4 weeks. The maximally  tolerated dose (MTD) of lucatumumab was 3.0 mg/kg. Four patients at doses of 4.5, Context: (4%) maintained a partial response for ≥8 months. These findings indicate that  single-agent lucatumumab was well tolerated up to 4·5 mg/kg with modest clinical  activity in relapsed/refractory MM, warranting further study as a combination  therapy., Context: h following the first infusion, and 124 h following the fourth infusion. In  summary, lucatumumab had acceptable tolerability, pharmacokinetics that  supported chronic dosing and pharmacodynamic target antagonism at doses of 3.0, Context: bezlotoxumab bind to and neutralize TcdA and TcdB, respectively. Bezlotoxumab  was recently approved by the FDA for reducing the recurrence of CDI. We have  previously shown that a single molecule of bezlotoxumab binds to two distinct","22475052, 22861192, 22475052, 22861192, 22475052, 28232034","No, lucatumumab is a fully humanized anti-CD40 antibody that blocks interaction of CD40L with CD40 and also mediates antibody-dependent cell-mediated cytotoxicity (ADCC).",22475052
What eye disease(s) are associated with ocular toxoplasmosis?,"Yes, retinochoroiditis is a major eye disease associated with ocular toxoplasmosis. This is mentioned in the background of the text where it states that ""Retinochoroiditis is the most common ophthalm","Context: BACKGROUND: Retinochoroiditis is the most common ocular manifestation of  congenital toxoplasmosis, but other associated ophthalmological pathologies can  also occur. The aim of this study was to determine the nature of the latter in, Context: strain, was used to infect pregnant females. Histological analysis of pre-natal  fetal eyes from infected female mice, did not show parasite infestation,  however, alterations were observed in the outer nuclear layer (ONL) and in the, Context: Ocular toxoplasmosis is present in 20% of infected immunocompetent individuals.  Toxoplasmosis is the most common cause of posterior uveitis in immunocompetent  subjects and congenital toxoplasmosis transmission was the first parasite to be, Context: toxoplasmosis and follow-up of 6 months or more was conducted. All patients were  seen at the Casey Eye Institute at the Oregon Health & Science University over a  9-year period (2003-2012). Demographic data, presence of RD and/or vitritis, and, Context: also analyzed. RESULTS: Thirty-five eyes of 28 patients with ocular toxoplasmosis and  sufficient follow-up were studied. Median age of patients was 40 years (range,  7-93 years). Median follow-up time was 22.5 months (range, 6-96 months). Four of, Context: These histological observations suggest that ocular lesions are not delayed  manifestations of toxoplasmosis. The eye was affected in the initial phase of  disease, and these alterations were of similar nature as those observed in mice","15906073, 17596951, 17596951, 25127047, 25127047, 17596951",Retinochoroiditis is the most frequent manifestation of congenital toxoplasmosis Infectious uveitis accounted for 37% of posterior uveitis cases of which toxoplasmosis was the most common cause. Toxoplasmosis was the most common cause of posterior uveitis (60%),"30332547, 25127047, 33060522, 31589483, 31429610, 32068467, 17596951, 15906073"
What is known about the effect of acupuncture in smoking cessation ?,"No, according to the context, acupuncture was not found to have a better efficacy in smoking cessation compared to sham acupuncture. However, combining acupuncture with behavior counseling or nicotine","Context: The use of alternative medicine for smoking cessation have been increasing  steadily in recent years. A series of clinical group studies was performed to  clarify the effect, outcome and success rate of an acupuncture treatment for, Context: The use of alternative medicine for smoking cessation have been increasing  steadily in recent years. A series of clinical group studies was performed to  clarify the effect, outcome and success rate of an acupuncture treatment for, Context: CONCLUSION: Our results showed that auricular acupuncture did not have a better  efficacy in smoking cessation compared to sham acupuncture. Combined acupuncture  with behavior counseling or with nicotine replacement therapy should be used in, Context: for smoking cessation. However, its efficacy still remains controversial. METHODS: We conducted a prospective, randomized, controlled trial using  auricular acupuncture for smoking cessation in 131 adults who wanted to stop, Context: BACKGROUND: Tobacco smoking is responsible for human diseases of the lung,  heart, circulatory system and various kinds of cancers, and is a serious public  health problem worldwide. Acupuncture has been promoted as a treatment modality, Context: AIM: To evaluate a simple, ear acupuncture treatment for the cessation of  smoking. METHOD: Randomized, single-blind, placebo-controlled trial of 78 currently  smoking volunteers from the general public. Volunteers attended an acupuncture","15861492, 15861492, 17698433, 17698433, 17698433, 10024707","Ear acupressure (EAP) and ear acupuncture have been used for smoking cessation, and some positive results have been reported. Auricular (ear) acupressure has been purported to be beneficial in achieving smoking cessation in some studies, while in others has been deemed insignificant. The combined acupuncture-education group showing the greatest effect from treatment.","17264832, 17698433, 10024707, 12356614, 18405159, 12416359, 22373002, 11154059, 16566674, 24030452, 15861492, 15004442"
List 3 indications for Bupropion,"Yes, the indications for bupropion are as follows: 1. Bupropion is used to treat depression, it has been found to be effective in managing symptoms of major depressive disorder. 2. It is also a","Context: were conducted from June 2003 through August 2004. No time limit was specified  in the searches, which were conducted using the search terms bupropion,  bupropion SR, and bupropion XL., Context: sustained release (SR), and extended release (XL). Extensive hepatic metabolism  of bupropion produces three pharmacologically active metabolites, which may  contribute to its clinical profile., Context: bupropion is being tested as a candidate treatment for psychostimulant drug  abuse, attention-deficit hyperactivity disorder (ADHD) and obesity. Bupropion is  available in three bioequivalent oral formulations, immediate release (IR),, Context: DATA SOURCES: Major efficacy trials and other reports were obtained and reviewed  from MEDLINE searches, review of abstracts from professional meetings, and the  bupropion SR manufacturer's databases. Searches of English-language articles, Context: cessation generally gained less bodyweight than placebo recipients. The benefits  of bupropion for preventing weight gain persisted after the completion of long  term, but not short term therapy. Bupropion was well tolerated in clinical, Context: alone, although differences were not statistically significant. The combination  was superior to nicotine patch alone. Data from a preliminary report of long  term bupropion treatment (52 weeks) showed that the drug was associated with","16027765, 17227286, 17227286, 16027765, 10804045, 10804045","Bupropion is used to treat Obesity, for smoking cessation and for depression","16831112, 15479310, 9554323, 17227286, 12043548, 18219560, 18264876, 26137782, 18619194, 15155135, 10804045, 27038550, 16546007, 25223901, 25661549, 25895022, 23859696, 21142259, 16027765, 21274361"
List the neurotransmitters that are metabolized by MAOA.,"Yes, according to the context, dopamine and serotonin (5-hydroxytryptamine or 5-HT) are two neurotransmitters metabolized by MAOA. This information is found in the first and","Context: Methamphetamine continues to be the most widely abused drug in Japan. Chronic  methamphetamine users show psychiatric signs, including methamphetamine  psychosis. Monoamine oxidase A (MAOA) is one of the major enzymes responsible, Context: OBJECTIVE: Monoamine oxidase-A (MAO-A) is a key mitochondrial enzyme that  metabolizes biogenic amine neurotransmitters such as dopamine and serotonin.  Individuals with atypical depression (AD) are particularly responsive to, Context: for the degradation of neurotransmitters. Abnormalities in MAO levels have been  related to a wide range of psychiatric disorders. We examined whether or not the  MAOA-u variable-number tandem repeat (VNTR) has a functional polymorphism in, Context: motor impulsiveness in BPD. Additionally, BPD subjects reported higher BIS-11  attentional impulsiveness versus ASPD participants (t(1,36)=2.3, p=0.025). CONCLUSION: These preliminary results suggest that MAOA-L may modulate the, Context: Monoamine oxidase A (MAOA) catalyzes monoamine neurotransmitters including  dopamine, 5-hydroxytryptamine (5-HT, serotonin), and norepinephrine. MAOA also  plays a key role in emotional regulation. The aim of this study was to, Context: administration, NSD-1015 (100 mg/kg ip) produced 88% and 96% inhibition of  hepatic and striatal MAO A and B activity respectively. Carbidopa (12.5 mg/kg  i.p.) and benserazide (50 mg/kg i.p.) had no effect on striatal MAO A activity","19368859, 19214141, 19368859, 29073746, 24510409, 12658372","The monoamine oxidase-A (MAOA) gene plays a vital role in the metabolism of neurotransmitters, e.g, serotonin, norepinephrine, and dopamine.","23761378, 24510409, 19456107, 25733484, 21554924, 20485326, 18227761, 24865426, 20204405, 24652311, 19368859, 19214141"
Summarize the cause of autosomal dominant Spinocerebellar Ataxia type 3.,"Yes, the cause of autosomal dominant Spinocerebellar Ataxia type 3 is the expansion of trinucleotide CAG repeats in the gene encoding ataxin-3. This genetic mutation","Context: spinocerebellar ataxia type 3., Context: Spinocerebellar ataxia type 1 (SCA1), spinocerebellar ataxia type 2 (SCA2) and  Machado-Joseph disease or spinocerebellar ataxia type 3 (MJD/SCA3) are three  distinctive forms of autosomal dominant spinocerebellar ataxia (SCA) caused by, Context: AIMS: Spinocerebellar ataxia type 3 (SCA3) is an inherited spinocerebellar  ataxia caused by the expansion of trinucleotide CAG repeats in the gene encoding  ataxin-3. The clinical manifestations of SCA3 include peripheral neuropathy,, Context: of spinocerebellar ataxia type 3 remains unclear., Context: disease. Despite several positive case reports and short studies, further  controlled researches have failed to substantiate any positive effects of  lithium exposure in amyotrophic lateral sclerosis. In spinocerebellar ataxia,, Context: the most common spinocerebellar ataxias based on patient numbers that exceed  those of previous studies and confirms that disease progression is faster in  SCA1, intermediate in SCA2 and SCA3 and slower in SCA6, with similar rates of","23659897, 9629399, 23617879, 20007218, 29400298, 32266540",Spinocerebellar ataxia type 3/Machado-Joseph disease (SCA3/MJD) is a progressive autosomal dominant neurodegenerative disease caused by abnormal CAG repeats in the exon 10 of ATXN3.,"33219521, 9048937, 32266540, 32346735, 34535635, 26123252, 34159894, 9629399, 34565721, 15316156, 31639609"
Are retroviruses used for gene therapy?,"Yes, retroviruses are used for gene therapy. This is evident from the context as it mentions therapeutic application of recombinant retroviruses and other integrating gene transfer vectors in gene therapy clinical trials. Additionally,","Context: The therapeutic application of recombinant retroviruses and other integrating  gene transfer vectors has been limited by problems of vector expression and  vector-mediated genotoxicity. These problems arise in large part from the, Context: Mobile genetic elements with the ability to integrate genetic information into  chromosomes can cause disease over short periods of time and shape genomes over  eons. These elements can be used for functional genomics, gene transfer and, Context: gene therapy clinical trials involving onco-retroviral vectors. However, the  main safety concern of using onco-retroviral vectors is related to the risk of  malignant transformation following oncogene activation due to random, Context: Extensive gene therapy studies in preclinical models and in clinical trials  underscore the relative safety of onco-retroviral vectors. Up until recently, no  adverse effects have been reported in nearly 2000 patients that were enrolled in, Context: The past 15 years opened new avenues for retrovirus and retroelement research.  Not surprisingly, they stemmed from essential knowledge collected in the past,  which remains the ground of the present and therefore should be remembered., Context: cDNA leads to complete correction of the enzymatic deficiency. The newly  synthesized enzyme is correctly processed and targeted to the lysosomes in  transduced cells. Cross-correction experiments using retrovirus-modified cells","21247248, 16717285, 14683449, 14683449, 21943326, 10757351","Gene therapy is one of the most promising and active fields in therapeutic research. Gene therapy is a treatment option that introduces genetic material in vivo or ex vivo into the cells of an affected organism in order to: exchange a defective gene; manipulate a disease-related gene; or introduce an additional gene copy for overexpression of the encoded protein to generate a curative biological effect. Somatic gene therapy is gene transfer by a specific vector to a somatic cell; in contrast to germline gene therapy, the modification of the cell is restricted to the recipient and cannot be passed to her/his progeny. High efficiency of gene transfer, high specificity for the target cells, long-lasting expression of the transgene and safety without adverse reactions are the desired characteristics of an ideal vector for gene transfer. Retroviral (gretroviral and lentiviral) vectors have now been used in more than 350 gene-therapy studies. Retroviral vectors are particularly suited for gene-correction of cells due to long-term and stable expression of the transferred transgene(s), and also because little effort is required for their cloning and production. Several monogenic inherited diseases, mostly immunodeficiencies, can now be successfully treated.","24120896, 16251873, 12686720, 23921576, 15912200, 23843498, 23884859, 19435468, 23845071, 23860311, 23845947, 23845948, 21943326"
What is Dysphoric Milk Ejection Reflex?,"Yes, Dysphoric Milk Ejection Reflex (D-MER) is a condition where women experience abrupt negative emotions, such as self-loathing or dysphoria, just before milk release at the initiation of each","Context: BACKGROUND: Dysphoric milk ejection reflex (D-MER) is characterized by an abrupt  dysphoria, or undesirable feeling that occurs with the MER and continues for no  more than a few minutes. After milk ejection, the dysphoria vanishes., Context: Dysphoric milk ejection reflex (D-MER) results in waves of negative emotions  that last from shortly before initial milk ejection until baby starts to feed  vigorously Symptoms may decrease by 3 months or they may continue throughout the, Context: Dysphoric Milk Ejection Reflex (D-MER) is an abrupt emotional ""drop"" that occurs  in some women just before milk release and continues for not more than a few  minutes. The brief negative feelings range in severity from wistfulness to, Context: CASE SERIES: This case series provides a report of three women who have  experienced D-MER. All three women described the sudden onset of negative  feelings at the initiation of each breastfeeding session. The dysphoria vanished  after each milk ejection., Context: self-loathing, and appear to have a physiological cause. The authors suggest  that an abrupt drop in dopamine may occur when milk release is triggered,  resulting in a real or relative brief dopamine deficit for affected women., Context: Dysphoric milk ejection reflex (D-MER) results in waves of negative emotions  that last from shortly before initial milk ejection until baby starts to feed  vigorously Symptoms may decrease by 3 months or they may continue throughout the","29115857, 20443435, 21645333, 29115857, 21645333, 20443435","Dysphoric milk ejection reflex (D-MER) is characterized by an abrupt dysphoria, or undesirable feeling that occurs with the MER and continues for no more than a few minutes. After milk ejection, the dysphoria vanishes. Symptoms may decrease by 3 months or they may continue throughout the breastfeeding period.","29115857, 20443435, 21645333"
Are tumour specific antigens originating from known protein coding genes?,"Yes, tumour specific antigens can originate from known protein coding genes. This is suggested in the context by mentioning that the identification of tumour antigens can be accelerated by methods allowing the amplification of gene products selectively","Context: indirect evidence is still missing. It is thus unknown how many tumours express  tumour specific antigen at all and whether these putative antigens are of unique  specificity or are shared by certain groups of (histologically related), Context: Early investigations into the immune surveillance of chemically-induced sarcomas  led to two important concepts in tumour immunobiology: one, tumour rejection can  be elicited by immune recognition of tumour antigens; and two, tumours express, Context: Tumour-derived peptides eluted from MHC molecules of tumour tissue are also a  promising source of antigen. Tumour antigens are mostly of weak immunogenicity,  because the vast majority are tumour-associated differentiation antigens already, Context: The identification of tumour antigens can now be accelerated by methods allowing  the amplification of gene products selectively or preferentially transcribed in  the tumour. However, determining the potential immunogenicity of such gene, Context: Meningitis and sepsis caused by serogroup B meningococcus are two severe  diseases that still cause significant mortality. To date there is no universal  vaccine that prevents these diseases. In this work, five antigens discovered by, Context: survival. When combined with dendritic cell vaccination, survival was  synergistically enhanced with a concomitant decrease in TAMs and an increase in  CD8+ T-cell numbers and functionality. Total as well as tumor antigen-specific","1423320, 12766764, 11599633, 11599633, 16825336, 28536100","Heat-shock proteins (HSPs) function as ubiquitous tumour-specific antigens, with the specificity residing in a population of bound peptides that identify the tissue of origin of the HSP. Tumour antigens are mostly of weak immunogenicity, because the vast majority are tumour-associated differentiation antigens already 'seen' by the patient's immune system.","7517178, 12766764, 21388431, 11599633, 1423320, 23561850, 18031135"
Which gene is primarily associated with the Saethre-Chotzen syndrome?,"Yes, the TWIST1 gene is primarily associated with the Saethre-Chotzen syndrome. This gene, located on chromosome 7p21.2, encodes a transcription factor that contains DNA binding and hel","Context: phenotype of Saethre-Chotzen syndrome. Array CGH also showed deletion of four  other genes at 7p21.1 (SNX13, PRPS1L1, HD9C9, and FERD3L) and the deletion of  six genes (CACNA2D2, C3orf18, HEMK1, CISH, MAPKAPK3, and DOCK3) at 3p21.31. Our, Context: transcription factor with DNA binding and helix-loop-helix domains. Numerous  missense and nonsense mutations cluster in the functional domains, without any  apparent mutational hot spot. Two novel point mutations and one novel, Context: Saethre-Chotzen syndrome is caused by mutations in the TWIST gene on chromosome  7p21.2. However, Muenke et al. [(1997); Am J Hum Genet 91: 555-564] described a  new subgroup carrying the Pro250Arg mutation in the fibroblast growth factor, Context: Saethre-Chotzen syndrome. This differential diagnosis is of particular  importance, as it is an autosomal dominant trait. Therefore, the recurrence risk  for parents of an affected child can be 50% if one parent carries the mutation,, Context: BACKGROUND: Patients with Saethre-Chotzen syndrome have a heterogeneous  phenotype. The purpose of this study was to use the genotypic diagnosis of the  authors' series of patients with TWIST1-confirmed Saethre-Chotzen syndrome to, Context: Comprehensive studies in patients with the clinical diagnosis of Saethre-Chotzen  syndrome have demonstrated a TWIST gene abnormality in about 80%, up to 37% of  which may be large deletions [Johnson et al., 1998]. The gene deletions and","22628249, 10649491, 17036334, 9934984, 19952666, 10649491","Saethre-Chotzen syndrome is a craniosynostosis syndrome that is rarely diagnosed prenatally . It is caused by cytogenetic deletions or mutations of the TWIST1 gene . Of the 37 patients with classic features of the syndrome, the overall detection rate for TWIST mutations was 68% . Increased risk for developmental delay is associated with TWIST deletions .","19863427, 8988166, 20125191, 8988167, 19860490, 21811467, 12221714, 10649491, 11314068, 16502419, 9259286, 11772178, 29663378, 22628249, 19952666, 12116251, 22569119, 21814570, 15880747, 25118508, 30040876, 16251895, 17868088, 19483581, 9215678, 24585549, 14513358, 28521820, 15735646, 17437280, 10094188, 11248247, 15923834, 28220539"
Which R/bioconductor have been developed for copy number analysis?,"Yes, the R package copynumber and the R/Bioconductor data package have been developed for copy number analysis. The copynumber package offers a unified framework for segmentation of regions of copy number gain or loss in single","Context: algorithms, due to the emergence of very high density scans of copy number. RESULTS: A comprehensive Bioconductor package for copy number analysis is  presented. The package offers a unified framework for single sample,, Context: computationally highly efficient algorithm is proposed that utilizes  vector-based operations in R. Three case studies are presented. CONCLUSIONS: The R package copynumber is a software suite for segmentation of, Context: regions of copy number gain or loss. All analyses are performed in the  statistical environment R., Context: package, a new R tool package and a new R/Bioconductor data package to  facilitate access for both manual and automated methods., Context: http://bioconductor.org/packages/release/bioc/html/RCAS.html and  http://rcas.mdc-berlin.de., Context: available at http://bioconductor.org . The local web application is available at  Additional file 2. A documentation of the R package (Additional file 1) as well  as the web application (Additional file 2) with detailed descriptions, examples","23442169, 23442169, 22523482, 24194598, 28334930, 28241736","CNVRanger, seqCNA, iGC, PLRS, SomatiCA, Copynumber, crlmm, KC-SMARTR are all R/bioconductor packages for copy number analysis","21070656, 28088185, 24597965, 23419375, 24265680, 31392308, 23442169, 22523482"
What are the CADD scores?,"No, the context does not provide explicit details about what CADD scores are. However, it mentions that CADD scores, software, and documentation are available at <https://cadd.gs.washington.edu>. Based on this information","Context: American Heart Association recommendation of a score of more than 2. RESULTS: We enrolled 2056 patients (mean age 68.0 yr, 1046 (50.9%) women) who  had a rate of stroke of 1.8% at 7 days and 3.2% at 90 days. An ABCD2 score of, Context: Interface and improved mechanisms for integrating CADD scores into other tools  or applications. CADD scores, software and documentation are available at  https://cadd.gs.washington.edu., Context: Interface and improved mechanisms for integrating CADD scores into other tools  or applications. CADD scores, software and documentation are available at  https://cadd.gs.washington.edu., Context: 15q21-q23 for both families. Combining the two families gave a two-point LOD  score of 10.65 for D15S993. The alpha-tropomyosin-1 gene (TPM1) located within  this region is the strongest candidate gene. However, no mutations were found in, Context: on ID-MS traceable method such as compensated Jaffe (cJafCreat) and enzymatic  (EnzCreat) methods. DESIGN AND METHODS: Potential protein-related interferences in creatinine  determination were evaluated using dialysates spiked with albumin. MELD score,, Context: the ABCD(2) score. We aimed to prospectively validate the former score in a  multicenter case series study. METHODS: We prospectively calculated the ABCD(2) score (age [> or = 60 years: 1","21646462, 30371827, 30371827, 12805120, 22178107, 20421579","Combined Annotation-Dependent Depletion (CADD) is a widely used measure of variant deleteriousness that can effectively prioritize causal variants in genetic analyses, particularly highly penetrant contributors to severe Mendelian disorders. CADD is an integrative annotation built from more than 60 genomic features, and can score human single nucleotide variants and short insertion and deletions anywhere in the reference assembly.","25871441, 30371827, 27148939, 29340599"
Describe the mechanism of action of Lisocabtagene maraleucel.,"No, the context does not provide explicit details on the mechanism of action of Lisocabtagene maraleucel. The context mentions this product as one of the CAR T-cell products for treating relapsed/refractory aggressive","Context: It has been established that the urothelial mucin layer functions as a bacterial  anti-adherence factor. Intravesical Bacillus Calmette-Guerin is used to treat  patients with superficial bladder cancer. The proposed mechanism of action of, Context: selection for the management of patients with relapsed/refractory aggressive  B-cell lymphomas., Context: tisagenlecleucel, and lisocabtagene maraleucel. These products differ in  construct, manufacturing, clinical trial design and toxicity profile. Patient  selection for CAR T-cells, and the ideal product for a given patient, involves, Context: inhibitory action of this compound., Context: review. A review of PDP, its current treatment and limitations is followed by  the rationale for development of pimavanserin. The mechanism of action,  preclinical data, pharmacokinetics, pharmacodynamics, and clinical data, Context: the only chaotropic agent. LiCl disruption is used in order to preserve the  solubilized proteins in a substantially ""native"" configuration. The extraction  mixtures were characterized by sucrose density gradient analysis and the","1732628, 32611216, 32611216, 8822090, 27609312, 6284743","Lisocabtagene maraleucel is an autologous, CD19-directed, chimeric antigen receptor (CAR) T-cell product.","31099671, 32611216, 32670869, 31899702, 32888407, 31677848, 31648957, 32740094"
Does surgery for ovarian endometriomas improve fertility?,"Yes, according to the context, surgery for ovarian endometriomas can improve fertility. This is because endometrioma surgery seems to enhance the success rates of fertility treatment, as suggested by the study's results on live","Context: OBJECTIVE: To investigate whether conservative surgery on ovarian endometriomas  before an IVF cycle improves fertility outcomes. DESIGN: Retrospective, matched case-control study. SETTING: Two academic IVF programs., Context: complications of laparoscopic surgery. Conversely, conservative surgical  treatment of ovarian endometriomas in symptomatic women does not impair IVF or  intracytoplasmic sperm injection success rates., Context: PATIENT(S): One hundred eighty-nine women with endometriomas who underwent IVF  treatment: 56 women proceeded directly to IVF, and 133 first underwent  conservative ovarian surgery. INTERVENTION(S): Controlled ovarian hyperstimulation and IVF-ET., Context: RESULTS: In both cases histopathological examinations showed: cystis picea  endometriotica ovarii. Both patients delivered at term. CONCLUSIONS: Ovarian endometriomas does not exclude fertility. Surgical, Context: long-term reproductive performance of the affected patients, with little or no  contribution from surgery. Furthermore, endometrioma surgery seems to improve  the success rates of fertility treatment., Context: live birth rates. In conclusion, ovarian endometriosis does not reduce IVF  outcome compared with tubal factor. Furthermore, laparoscopic removal of  endometriomas does not improve IVF results, but may cause a decrease of ovarian","15136074, 15136074, 15136074, 11526777, 24231199, 21679474","Yes, endometrioma surgery seems to improve the success rates of fertility treatment.","12419041, 15136074, 17399914, 23759693, 21561807, 8737616, 16034960, 7202738, 21679474, 18425908, 21764126, 2943896, 11526777, 22695290, 23277022, 24231199"
Which enzyme is targeted by Evolocumab?,"No, the context does not specify that Evolocumab targets an enzyme. Instead, it is a monoclonal antibody inhibiting the protein PCSK9 (proprotein convertase subtilisin/ke","Context: tolerate statins or full doses of these drugs. Thus, there is a need for  additional effective LDL-C reducing agents. AREAS COVERED: Evolocumab (AMG145) is a monoclonal antibody inhibiting the, Context: rationale and design of the Goal Achievement After Utilizing an anti-PCSK9  Antibody in Statin-Intolerant Subjects 2 (GAUSS-2) trial, a randomized,  double-blind, ezetimibe-controlled, multicenter phase 3 study to evaluate the, Context: action are in advanced phase of development or have just been approved. AREAS COVERED: Evolocumab and alirocumab are fully human monoclonal antibodies  inhibiting the proprotein convertase subtilisin/kexin type 9 (PCSK9) that binds, Context: biological processes. Furthermore, E3s are enzymes that determine the  specificity of protein substrates; they represent a class of ""drugable"" targets  for pharmaceutical intervention. In this review, I will mainly focus on E3, Context: the enzyme's active site., Context: Tissue transglutaminase (TG2) modifies proteins and peptides by transamidation  or deamidation of specific glutamine residues. TG2 also has a central role in  the pathogenesis of celiac disease. The enzyme is both the target of","24661068, 24477778, 24961142, 14688465, 8798387, 14747475",Evolocumab (AMG145) is a fully human monoclonal antibody to proprotein convertase subtilisin/kexin type 9 (PCSK9) that demonstrated marked reductions in plasma low-density lipoprotein cholesterol concentrations in statin-intolerant patients.,"24859266, 24694531, 24662398, 24691094, 25470376, 24825642, 24953393, 25079474, 24953396, 25002170, 24678979, 24598985, 24661068, 24477778, 24481874, 24255061, 25282519, 25282520, 24509273, 25052769, 24284914, 24373748, 24961142, 25410046"
Which annotated database of A-to-I RNA editing is available?,"Yes, RADAR is an annotated database of A-to-I RNA editing that is available at <http://RNAedit.com>. It includes a comprehensive collection of A-to-I RNA editing sites identified in","Context: We present RADAR--a rigorously annotated database of A-to-I RNA editing  (available at http://RNAedit.com). The identification of A-to-I RNA editing  sites has been dramatically accelerated in the past few years by high-throughput, Context: We present RADAR--a rigorously annotated database of A-to-I RNA editing  (available at http://RNAedit.com). The identification of A-to-I RNA editing  sites has been dramatically accelerated in the past few years by high-throughput, Context: RNA sequencing studies. RADAR includes a comprehensive collection of A-to-I RNA  editing sites identified in humans (Homo sapiens), mice (Mus musculus) and flies  (Drosophila melanogaster), together with extensive manually curated annotations, Context: BACKGROUND: RNA editing is a co-transcriptional modification that increases the  molecular diversity, alters secondary structure and protein coding sequences by  changing the sequence of transcripts. The most common RNA editing modification, Context: RMBase provides a genome browser and a web-based modTool to query, annotate and  visualize various RNA modifications. This database will help expand our  understanding of potential functions of RNA modifications., Context: present study also suggests that linkage of editing should be considered in  elucidating the functional consequences of RNA editing.","24163250, 24163250, 24163250, 28049429, 26464443, 29048557","RADAR is a rigorously annotated database of A-to-I RNA editing. RADAR includes a comprehensive collection of A-to-I RNA editing sites identified in humans (Homo sapiens), mice (Mus musculus) and flies (Drosophila melanogaster), together with extensive manually curated annotations for each editing site. RADAR also includes an expandable listing of tissue-specific editing levels for each editing site, which will facilitate the assignment of biological functions to specific editing sites.",24163250
List interaction partners for the protein GATA1.,"Yes, according to the context, one of the interaction partners for the protein GATA1 is Ski. This information is derived from the BioGRID database of physical and genetic interactions, which shows that there is a reported interaction between GATA1","Context: characters of its developers' nicknames), is presented. GIBA implements a two  step procedure to a given dataset of protein-protein interaction data. First, a  clustering algorithm is applied to the interaction data, which is then followed, Context: and tumor suppressors. These divergent roles of Ski are probably dependent on  Ski's capacity to bind multiple partners with disparate functions. In  particular, Ski alters the growth and differentiation program of erythroid, Context: The Biological General Repository for Interaction Datasets (BioGRID:  https://thebiogrid.org) is an open access database dedicated to the annotation  and archival of protein, genetic and chemical interactions for all major model, Context: with the NGLY1 gene according to BioGRID database of physical and genetic  interactions were analysed with STRING Protein-Protein interaction database.  Network analysis identified FAF1 (Fas-Associated Factor 1), an, Context: determined protein interacting pairs. The goal is to study the extent of protein  interaction partners with increasing phylogenetic distance, using an automated  method. We have thus detected component pairs within seven entire genome, Context: In order to understand how biological systems function it is necessary to  determine the interactions and associations between proteins. Some proteins,  involved in a common biological process and encoded by separate genes in one","19534736, 15542823, 27980099, 26228302, 18546511, 20851221","GATA-1 interact with factor Gfi-1b, the repressive MeCP1 complex, the chromatin remodeling ACF/WCRF complex, FOG-1, TAL-1, Ldb-1 and LMO2-C.","16339652, 17108004, 18844071, 15542823, 12032775, 21532337, 20959602, 15920471"
Which proteins does RG-7992 target?,"No, the context does not provide information about which proteins RG7112 targets. The context only mentions that RG7112 is a potent and selective member of the nutlin family of MDM2 ant","Context: chronic pancreatitis (n = 3), and pancreatic cancer (n = 3). RESULTS: We identified 525 nonredundant proteins from 9 specimens. Implementing  our filtering criteria, 78, 15, and 21 proteins were identified exclusively in, Context: Nuclear speckles (NSs) serve as splicing factor storage sites. In this study, we  unexpectedly found that many endogenous intronless mRNAs, which do not undergo  splicing, associate with NSs. These associations do not require transcription,, Context: cancer therapy. RG7112 is a potent and selective member of the nutlin family of  MDM2 antagonists currently in phase I clinical studies. RG7112 binds MDM2 with  high affinity (K(D) ~ 11 nmol/L), blocking its interactions with p53 in vitro. A, Context: trastuzumab. In addition to potent in vitro cytotoxicity, MRG002 showed tumor  regression in both high- and medium-to-low HER2 expressing in vivo xenograft  models. Furthermore, MRG002 showed enhanced antitumor activity when used in, Context: granule fraction (RG). This subset, characterized by extended length and  adenylate-uridylate (AU)-rich motifs, is highly enriched with genes critical for  cell survival and proliferation. This pattern of RG targeting was conserved for, Context: antibody coupling requires 4 h. IP or co-IP is accomplished by incubating the  antibody resin with the protein sample. Washes and elutions are carried out in a  spin column to reduce resin loss and decrease assay time. Target proteins are","22015969, 30194269, 23400593, 34532642, 29576526, 12915006",BFKB8488A is a bispecific antibody against FGFR1 and KLB.,33139537
Is Tranexamic acid effective for intracerebral haemorrhage?,"Yes, tranexamic acid has been found to be effective in reducing post-operative and traumatic bleeding. However, its specific impact on halting hematoma expansion in intracerebral hemorrhage (ICH","Context: INTRODUCTION: Seizures are common after intracerebral haemorrhage. Tranexamic  acid increases the risk of seizures in non-intracerebral haemorrhage population  but its effect on post-intracerebral haemorrhage seizures is unknown. We, Context: INTRODUCTION: Seizures are common after intracerebral haemorrhage. Tranexamic  acid increases the risk of seizures in non-intracerebral haemorrhage population  but its effect on post-intracerebral haemorrhage seizures is unknown. We, Context: explored the risk factors and outcomes of seizures after intracerebral  haemorrhage and if tranexamic acid increased the risk of seizures in the  Tranexamic acid for IntraCerebral Haemorrhage-2 trial., Context: PURPOSE: Haematoma expansion is a devastating complication of intracerebral  haemorrhage (ICH) with no established treatment. Tranexamic acid had been an  effective haemostatic agent in reducing post-operative and traumatic bleeding., Context: intracerebral haemorrhage (ICH). DESIGN: The TICH-2 (Tranexamic acid for hyperacute primary IntraCerebral  Haemorrhage) study was a pragmatic, Phase III, prospective, double-blind,  randomised placebo-controlled trial., Context: studies using search strategies incorporating the terms 'intracerebral  haemorrhage', 'tranexamic acid' and 'antifibrinolytic'. Authors of ongoing  clinical trials were contacted for further details.","32637645, 32637645, 32637645, 31008298, 31322116, 31008298",No. According to clinical trial data tranexamic acid does not improve outcomes of patients with intracerebral haemorrhage.,"31322116, 31008298, 32637645, 33128912, 29778325"
Which pathway is activated by ficolin-3?,"Yes, the lectin complement pathway. Ficolin-3 is one of the initiators of this pathway, as stated in the context.","Context: from the other ficolins and MBL. We discovered several unique properties of  Ficolin-3 showing that FCN3 is the most highly expressed gene in liver and lung  among the lectin complement pathway initiators. Moreover, Ficolin-3 has a high, Context: complement activating potential and is the only collagenase proteolytic  resistant molecule among the lectin complement pathway initiators., Context: calcium. Ficolin-3 also augmented phagocytosis of H. alvei by macrophages and  displayed bactericidal activity. Additionally, Ficolin-3 inhibited host cells'  response to TLR4/MD-2/CD14-LPS dependent NF-κB activation. This is the first, Context: was sequenced in 237 healthy Danish Caucasians. The relevance of polymorphisms  was assessed with antibodies against Ficolin-3 in a novel ELISA system and by  production of recombinant Ficolin-3 variants. Ficolin-3 serum profiles were, Context: RESULTS: In patients, no changes were detected for ficolin-3 compared with  controls. Notably, however, ficolin-3-mediated functional LCP activity was  reduced. Low levels of plasma ficolin-3 and ficolin-3-mediated functional LCP, Context: in the assay independent of the Ficolin-3 concentration.","18006063, 18006063, 25178935, 18261799, 24336142, 25069872",Ficolin-3 activates lectin complement pathway.,"18261799, 19939495, 21890891, 24336142, 18006063, 25069872, 25178935, 19535802, 23142462"
What animal is thought to be the host for the Coronavirus causing MERS?,"Yes, camels are the animals thought to be the host for the Coronavirus causing MERS. This is because MERS-CoV has been transmitted from camels in the Middle East and most laboratory animals are refractory or only","Context: Two novel coronaviruses have emerged to cause severe disease in humans. While  bats may be the primary reservoir for both viruses, SARS coronavirus (SARS-CoV)  likely crossed into humans from civets in China, and MERS coronavirus (MERS-CoV), Context: in the transmission of pathogens is of importance to understand the epidemiology  of the disease. Little is known about MERS-CoV animal host range. In this paper,  experimental data on potential hosts for MERS-CoV is reviewed. Advantages and, Context: against emerging viruses. With SARS-CoV, several animal species were permissive  to infection. In contrast, most laboratory animals are refractory or only  semi-permissive to infection with MERS-CoV. This host-range restriction is, Context: in the transmission of pathogens is of importance to understand the epidemiology  of the disease. Little is known about MERS-CoV animal host range. In this paper,  experimental data on potential hosts for MERS-CoV is reviewed. Advantages and, Context: has been transmitted from camels in the Middle East. Unlike SARS-CoV that  resolved within a year, continued introductions of MERS-CoV present an on-going  public health threat. Animal models are needed to evaluate countermeasures, Context: Two novel coronaviruses have emerged to cause severe disease in humans. While  bats may be the primary reservoir for both viruses, SARS coronavirus (SARS-CoV)  likely crossed into humans from civets in China, and MERS coronavirus (MERS-CoV)","25791336, 28616501, 25791336, 28616501, 25791336, 25791336",The animal thought to be the host for the Coronavirus causing MERS is camels.,"25791336, 29239118, 29336306, 30146782"
Describe RCandy,"Yes, RCandy is a tool for detecting genomic regions recently affected by recombination. It is platform-independent and has been tested on Windows, Linux, and MacOSX. The source code comes with a detailed vignette","Context: detect genomic regions recently affected by recombination. Exploration and  visualization of such recombination events can reveal valuable biological  insights, but it remains challenging. Here, we present RCandy, a, Context: under the MIT license. It is platform-independent and has been tested on  Windows, Linux and MacOSX. The source code comes together with a detailed  vignette available on GitHub at https://github.com/ChrispinChaguza/RCandy., Context: under the MIT license. It is platform-independent and has been tested on  Windows, Linux and MacOSX. The source code comes together with a detailed  vignette available on GitHub at https://github.com/ChrispinChaguza/RCandy., Context: detect genomic regions recently affected by recombination. Exploration and  visualization of such recombination events can reveal valuable biological  insights, but it remains challenging. Here, we present RCandy, a, Context: regions of interest obtained from various RNA-based omics technologies. The  design of RCAS is modular, which enables flexible usage and convenient  integration with other bioinformatics workflows. RCAS is an R/Bioconductor, Context: of different biological events that involve RNAs. In addition, the array of  different interfaces and deployment options adds the convenience of use for  different levels of users. RCAS is available at","34864895, 34864895, 34864895, 34864895, 28334930, 28334930","RCandy is a platform-independent R package for rapid, simple, and flexible visualisation of recombination events in bacterial genomes.",34864895
Which part of the TNFR2 gene is genetically associated with Systemic Lupus Erythematosus?,"Yes, in the context, a polymorphism (Met196Arg) in the TNFR2 gene is genetically associated with Systemic Lupus Erythematosus (SLE) in Japanese patients.","Context: A polymorphism in high-affinity receptor of TNF (TNFR2) gene, Met196Arg, was  reported to be associated with systemic lupus erythematosus (SLE) in Japanese,  whereas the association could not be found in Europeans at all and this, Context: A polymorphism in high-affinity receptor of TNF (TNFR2) gene, Met196Arg, was  reported to be associated with systemic lupus erythematosus (SLE) in Japanese,  whereas the association could not be found in Europeans at all and this, Context: study were to examine the TNFR2 polymorphism in Japanese patients with SLE and  to investigate its association with other autoimmune diseases accompanied by  vasculitis, mixed connective tissue disease, Buerger's disease, and Takayasu's, Context: represents an apparent discrepancy. The association, then, should be tested in  other populations to clarify the possible involvement, if any, of the TNFR2  polymorphism in SLE or other related autoimmune diseases. The purposes of this, Context: A number of studies reported associations of HLA-DRB1, TNFalpha (TNF) promoter  and TNF receptor II (TNFR2, TNFRSF1B) polymorphisms with systemic lupus  erythematosus (SLE), however, the results have often been inconsistent. Such, Context: Multiple genetic as well as environmental factors are considered to be involved  in the development of systemic lupus erythematosus (SLE). A number of previous  studies have suggested a possible role for tumor necrosis factor (TNF) in the","11169260, 11169260, 11169260, 11169260, 11607787, 10395102",There is a TNFR2 3' flanking region polymorphism in systemic lupus erythematosus.,"11607787, 11169260, 11196716, 11197692, 10395102"
Which resource has been developed in order to study the transcriptional regulation of GABAergic cell fate?,"No, the context does not provide information about a resource developed to study the transcriptional regulation of GABAergic cell fate. The context mentions studies on T-cell fate decision processes and transcription of Th2-specific genes but","Context: molecule databases. Augmenting many of the Web applications are custom  implementations of the BLAST program optimized to search specialized data sets.  All of these resources can be accessed through the NCBI home page at  www.ncbi.nlm.nih.gov., Context: coreceptors, CD4 and CD8. In the past few decades, extensive effort has been  made to understand the T-cell fate decision processes by studying regulation of  genes encoding the coreceptors and selection processes. These studies have, Context: All of these resources can be accessed through the NCBI home page at  www.ncbi.nlm.nih.gov., Context: transcription of these 26 Th2-specific genes, and 10 genes showed increased  transcription in a GATA3-dependent manner, whereas 16 genes showed no  significant responses. The transcription of the 16 GATA3-nonresponding genes was, Context: the stomach and liver. GATA4 is epigenetically silenced by hypermethylation of  primer region in many types of cancers including gastric cancer. The aim of this  study is to investigate the expression and epigenetic regulation of GATA4 in, Context: available through the NCBI Website. NCBI resources include Entrez, the Entrez  Programming Utilities, MyNCBI, PubMed, PubMed Central (PMC), Gene, the NCBI  Taxonomy Browser, BLAST, BLAST Link (BLink), Primer-BLAST, COBALT, Splign,","21097890, 25591463, 22140104, 21536806, 22472323, 22140104",Subpallial Enhancer Transgenic Lines is a data and tool resource to study transcriptional regulation of GABAergic cell fate.,27710791
In which cellular compartment do stress granules localize?,"Yes, stress granules localize in the cytoplasm. This is stated explicitly in the context as cytoplasmic foci colocalized with mutant FUS inclusions and cytoplasmic FUS was recruited","Context: cytoplasmic foci (i.e. stress granules) colocalized with the mutant FUS  inclusions but were absent in wild-type FUS-expressing cells. Processing bodies,  which are functionally related to stress granules, were adjacent to but not, Context: domains within FUS play a key role in its association to stress granules. While  there has been speculation that arginine methylation within these RGG domains  modulates the incorporation of FUS into stress granules, our results demonstrate, Context: granules where their decay and storage, respectively, are directed. Here, we  find that several mRNAs are localized to granules in unstressed, actively  growing cells. These granules play a key role in the stress-dependent formation, Context: cytoplasm. Cytoplasmic FUS was recruited into stress granules, which showed a  time-dependent decrease in all subjects. However, in the FUS P525L fibroblasts,  the granules persisted longer, and they were more numerous than those detected, Context: number of cell types. We have found that PABP4, similarly to PABP1, is a  diffusely cytoplasmic protein that can be localised to stress granules. However,  UV exposure unexpectedly relocalised both proteins to the nucleus. Nuclear, Context: co-localize in ALS motor neurons. TDP-43 was observed to co-localize to RNA  transport granules (Staufen immunoreactive) in both control and ALS spinal motor  neurons. In contrast, both stress granules (TIA-1 immunoreactive) and processing","20674093, 24090136, 25437551, 29035885, 21940797, 19815002",cytoplasm,"29298433, 23474818, 27057671, 25148713, 29035885, 28894257, 23982513, 22383896"
Entresto is composed of which two drugs?,"Yes, Entresto is composed of valsartan and sacubitril. Valsartan is an angiotensin receptor blocker and sacubitril is a neprilysin inhibitor prodrug. They","Context: Medicines Agency (EMEA), consequently, off-label use is habitual in Europe. Most  of the drugs improve only one or two symptoms; no drug capable of overall  symptom control is yet available. Furthermore, different classes of drugs with, Context: (entresto) for possible treatment of HFrEF. CONCLUSION: In this article, we will discuss the failure of previous treatment  modalities and the promise that LCZ696 (entresto) may hold for treating patients  with HFpEF., Context: developed for HIV-1. By contrast, small molecule inhibitors of the HIV-1 enzymes  reverse transcriptase, integrase, and protease have been developed that  effectively block virus replication. Three different drug compounds are commonly, Context: composition of the holoreceptor. For the benzodiazepines, barbiturates, and  loreclezole, actions at the GABAAR are the primary or only known mechanism of  antiseizure action. For topiramate, felbamate, retigabine, losigamone and, Context: receptor. Ibrutinib acts by inhibiting the Bruton's tyrosine kinase (BTK) while  idelalisib represents a first-in-class specific inhibitor of the  phosphoinositol-3 kinase (PI3K) delta isoform. Another class of drugs with, Context: as LCZ696 and currently marketed by Novartis as Entresto) combines the  angiotensin receptor blocker valsartan and the neprilysin inhibitor prodrug  sacubitril in a 1:1 ratio in a sodium supramolecular complex. Sacubitril is","21176430, 28676030, 34029457, 23683707, 24085367, 26976916","Entresto is composed of sacubitril and valsartan. It is newly FDA-approved medication that dually inhibits angiotensin and neprilysin, in the treatment of heart failure.","27378659, 27804100, 26992459, 26976916, 26417173, 27697814, 26873495, 27284124, 26466333, 26642078, 26975167"
What is the genetic basis of Rubinstein-Taybi syndrome?,"Yes, the genetic basis of Rubinstein-Taybi syndrome (RSTS) includes point mutations or deletions in specific genes. The two main genes associated with RSTS are CREBBP and EP300. These","Context: Rubinstein-Taybi syndrome (RSTS) is a rare autosomal dominant disorder  characterised by facial dysmorphisms, growth and psychomotor development delay,  and skeletal defects. The known genetic causes are point mutations or deletions, Context: young children. This case report demonstrates the ability of array-based  comparative genomic hybridization to offer a genome-wide analysis at high  resolution and provide information directly linked to the physical and genetic, Context: the pathogenesis of Rubinstein-Taybi syndrome. Additionally, due to insufficient  coverage of the human genome by conventional techniques, clinically significant  genomic imbalances may be undetected in unexplained syndromic conditions of, Context: Familial Rubinstein-Taybi syndrome (RTS) is very rare. Here we report on the 6th  and 7th case of inherited RTS. Family 1 presents with incomplete or mild RTS  over three generations; a 13-year-old girl (proband 1) with mild but typical, Context: Rubinstein-Taybi syndrome (RTS) is a well-defined syndrome characterized by  facial abnormalities, broad thumbs, broad big toes, and growth and mental  retardation as the main clinical features. RTS was shown to be associated with, Context: BACKGROUND: Rubinstein-Taybi syndrome (RTS) is a rare autosomal dominant  disorder (prevalence 1:125,000) characterised by broad thumbs and halluces,  facial dysmorphism, psychomotor development delay, skeletal defects,","20125191, 22269667, 22269667, 20684013, 14974086, 23432975","Rubinstein-Taybi syndrome (RTS) is a rare autosomal dominant disorder (prevalence 1:125,000) characterised by broad thumbs and halluces, facial dysmorphism, psychomotor development delay, skeletal defects, abnormalities in the posterior fossa and short stature. The known genetic causes are a microdeletion at 16p13.3 or mutations or deletions of the cAMP-response element binding protein-BP (CREBBP) (50-60% of the cases) and of the homologous gene E1A-binding protein (EP300) at 22q13 (5%). Direct sequencing of CREBBP performed in 13 RSTS patients identified the three zinc fingers (CH1, CH2, CH3) and HAT domain as mutational hotspots. Thus about 55% of patients have cytogenetic or molecular abnormalities in the Crebbp or E1A binding protein p300 (Ep300) gene, leaving the diagnosis in 45% of patients to rest on clinical features only.","7630403, 16359492, 22269667, 14974086, 18773673, 20684013, 23432975, 22303793, 15706485, 20689175, 22991675"
What are the biological roles proposed for proteins containing the SPRY domain?,"Yes, the SPRY domain in proteins is implicated in important biological pathways, including those that regulate innate and adaptive immunity. Additionally, an N-terminal region in ""SPRY-only"" proteins","Context: SPRY domain is based on a sequence repeat discovered in the splA kinase and  ryanodine receptors. The greater SPRY family is divided into the B30.2 (which  contains a PRY extension at the N-terminus) and ""SPRY-only"" sub-families. In, Context: The SPRY domain is a protein interaction module found in 77 murine and ~100  human proteins, and is implicated in important biological pathways, including  those that regulate innate and adaptive immunity. The current definition of the, Context: this brief review, we examine the current structural and biochemical literature  on SPRY/B30.2 domain involvement in key immune processes and highlight a  PRY-like 60 amino acid region in the N-terminus of ""SPRY-only"" proteins., Context: Phylogenetic, structural, and functional analyses suggest that this N-terminal  region is related to the PRY region of B30.2 and should be characterized as part  of an extended SPRY domain. Greater understanding of the functional importance, Context: the combination of SPRY with an additional domain, PRY. The combination of SPRY  and PRY to produce B30.2 domains may have been selected and maintained as a  component of immune defence., Context: of the N-terminal region in ""SPRY only"" proteins will enhance our ability to  interrogate SPRY interactions with their respective binding partners.","23139046, 23139046, 23139046, 23139046, 16313355, 23139046",defence against retroviral infection innate and adaptative immunity vesicular trafficking neural differentiation embryonic development,"12479811, 16648259, 16226405, 23139046, 22872646, 16313355, 15857996, 21035437, 23775985, 23886867, 15689398, 19184407, 23091002, 22337885, 17431422"
Can the yeast protein Abf1 act as insulator?,"No, there is no information in the context suggesting that the yeast protein Abf1 can act as an insulator. The context discusses Abf1's role in transcriptional activation, replication, silencing, and telom","Context: and other derived nematodes does so. CONCLUSION: Our findings show that CTCF and possibly chromatin insulation are  present in basal nematodes. We suggest that the insulator protein CTCF has been, Context: Abf1 binding sites in the promoters of mitochondrial RP genes evokes the  possibility that Abf1 might orchestrate still unexplored levels of co-regulation  involving growth-related gene networks in yeast cells., Context: promoters, and point to Abf1, which binds hundreds of non-RPG promoters within  the yeast genome, as a possible key regulatory switch in nutrient- and  stress-dependent transcriptional modulation. Moreover, the frequent presence of, Context: Abf1 binding sites in the promoters of mitochondrial RP genes evokes the  possibility that Abf1 might orchestrate still unexplored levels of co-regulation  involving growth-related gene networks in yeast cells., Context: Abf1 and Rap1 are general regulatory factors (GRFs) that contribute to  transcriptional activation of a large number of genes, as well as to  replication, silencing and telomere structure in yeast. In spite of their, Context: factors. Rif1 has recently been identified as a genome-wide regulator of  replication timing in fission yeast and in mammalian cells. However, previous  studies in budding yeast have suggested that Rif1's role in controlling","19712444, 27262581, 27262581, 27262581, 17158163, 24879017",Saccharomyces cerevisiae Rap1p and Abf1p proteins are endowed with a potent insulating capacity,12200417
Which viruses are best known to cause myocarditis?,"Yes, Coxsackie B viruses (types 1 to 5) are best known to cause myocarditis. They are the most frequent reported cause of acute viral myocarditis. The context also mentions","Context: Enteroviruses have been considered to be the most common cause of acute  myocarditis and possible consequence of dilated cardiomyopathy. Some  publications shed light to the role of other viruses in this disease as well., Context: CASE PRESENTATION: We report the cases of two pregnant Caucasian women (aged 29  and 30), with no pre-existing illness, presenting with respiratory  manifestations of H1N1 influenza virus infection in their third trimester. Both, Context: Coxsackie B viruses (types 1 to 5) are the most frequent reported cause of acute  viral myocarditis. To study the pathogenesis of the disease at the cellular  level, we simulated an infectious situation by infecting cultured human foetal, Context: frequent virus genome in explanted heart tissues. The identified viral sequences  proved previous viral infection, which could have played a role in the  development of dilated cardiomyopathy. Detection of different viruses in the, Context: other recovered without any long-term consequence. CONCLUSIONS: While it is not possible to ascertain retrospectively if  myocarditis was caused by either infection with H1N1 virus or as a result of, Context: left ventricular dysfunction and fibrosis and ways this can be targeted in the  setting of viral myocarditis.","18039618, 21756329, 3889351, 18039618, 21756329, 20875630","The most frequent viruses causing myocarditis are Enterovirus, Adenovirus and Coxsackie B viruses.","18039618, 8199011, 18277927, 3889351, 2641165, 14993139"
What is the relationship between thyroid hormone and inflammatory markers in heart failure patients?,"Yes, there is a relationship. In heart failure, decreases of thyroid hormone receptor levels occur and serum levels of T4 and T3 are decreased, which is part of the non-thyroidal illness syndrome. Additionally","Context: Cytokines and thyroid hormones are involved in the biochemical changes  associated to heart failure (HF). AIM: Aims of the study were to investigate: plasma circulating levels of the, Context: indicate that thyroid hormone metabolism (ie, the triiodothyronine to reverse  triiodothyronine ratio) is altered in a majority of patients with advanced  congestive heart failure and is an independent predictor of mortality. Currently, Context: In the failing heart, decreases of thyroid hormone receptor levels occur. In  addition, serum levels of T4 and T3 are decreased with heart failure in the  frame of the non-thyroidal illness syndrome. The decrease in T3 serves as an, Context: Though thyroid hormone abnormalities have been identified in many cardiac  conditions, the role of thyroid hormones in congestive heart failure has not  been well defined. In a population of patients with advanced heart failure, a, Context: heart failure (CHF), and ICU patients with myocardial infarction (MI).  Determination of the circulating serum levels of IL-6 and IL-10, thyroid  stimulating hormone (TSH), as well as total T4 and T3 was carried out., Context: Interest in the role of thyroid hormones (TH) in heart failure is steadily  increasing due to evidence for a physiological, homeostatic role of TH and the  effects of altered TH metabolism on the cardiovascular system, particularly in","19926244, 8333797, 19125327, 8936683, 18211669, 18221125",There is an inverse correlation between inflammatory markers (IL-6 and TNF alfa and PCR) and FT3 levels in patients with heart failure,"16524802, 19926244, 11021766, 15259379, 15521205, 12165115"
Is thrombophilia related to increased risk of miscarriage?,"Yes, according to the first sentence of the context, thrombophilia is indeed related to an increased risk of spontaneous abortion during the first trimester. This heightened risk is one of the primary associations made between thromboph","Context: mainly associated with the risk of spontaneous abortion during the first  trimester. In conclusion, thrombophilia was found to be considerably more common  in women with pregnancy-associated complications in comparison with the general, Context: macrovascular function were determined. RESULTS: Women with thrombophilia had significant lower total- and low-density  cholesterol, were more insulin sensitive, and had better microvascular function., Context: and cardiovascular diseases. METHODS: Ten women with thrombophilia were matched with 10 women without  thrombophilia for a history of hypertensive disorders during pregnancy.  Laboratory measurements: blood pressure, insulin sensitivity, and micro- and, Context: between pregnancy-associated complications and the presence of thrombophilia  risk factors, we studied the records of 414 women who had been examined for  inherited and acquired thrombophilia in the period 1996 to 2006 because of, Context: of thrombophilia was studied in 74 women with a history of perinatal mortality  (female cases) and 54 of their male partners (male cases). Seventy-one healthy  unrelated women after uneventful pregnancies only and 66 of their male partners, Context: PURPOSE: To determine if thrombophilia is a risk factor for placenta-mediated  pregnancy complications (PMPC) (i.e., preeclampsia, intrauterine growth  restriction (IUGR), placental abruption, intrauterine fetal death and recurrent  pregnancy loss).","19031171, 20860491, 20860491, 19031171, 15713144, 22543699","Thrombophilia has been found to be considerably more common in women with pregnancy-associated complications in comparison with the general population, and most frequently in conjunction with venous thromboembolism during pregnancy and the postpartum period. In particular there is an increased risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia. When counseling white women with a history of preeclampsia, screening for thrombophilia can be useful for preconceptional counseling and pregnancy management.","19031171, 18845284, 16962918, 19165673, 20860491, 11583310, 7986734, 22543699, 19135285, 22164918, 21380983, 15713144, 15027582"
Has Hesperidin any role as a Neuroprotective Agent?,"Yes, hesperidin does have a role as a neuroprotective agent. The context suggests that hesperidin has been shown to exert neuroprotective effects against 3-NP-induced Huntington's","Context: activities of enzymatic antioxidants, upregulation of Bax, cyt c, and caspases 3  and 9, and downregulation of Bcl-2, which were attenuated in the presence of  hesperidin. Our data suggests that hesperidin exerts its neuroprotective effect, Context: pretreated with hesperidin which also reduced cellular abnormalities induced by  3-NP. This study suggests a potential neuroprotective role of hesperidin against  3-NP-induced Huntington's disease-like manifestations. Such neuroprotection can, Context: flavonoids like hesperidin can be used for therapy of patients with brain injury  and depression. However, the exact mechanisms by which hesperidin indicates its  neuroprotective effects are not fully understood. The purpose of this study was, Context: minimal or no protective effects on the neuronal damage tested in this study.  Taken together, these results demonstrate potent antioxidant and neuroprotective  effects of hesperetin, implying its potential role in protecting neurons against, Context: or hesperidin may be a potential agent in the preventing of Alzheimer's disease  progression., Context: treatment was found to be non-significant. However, treatment of hesperidin  (50mg/kg) in combination with minocycline (25mg/kg) potentiated their  neuroprotective effect, which was significant as compared to their effects per","24205431, 22850463, 30352242, 16964766, 22383310, 24211676",Neuroprotective effect of hesperetin and nano-hesperetin on recognition memory impairment and the elevated oxygen stress in rat model of Alzheimer's disease,"28721824, 29687202, 30448580, 26381129, 24987179, 28761134, 22383310, 25860498, 30352242, 29136946, 21445621, 26342684, 24205431, 24211676, 16964766, 22850463"
Which disease the skin condition Necrobiosis lipoidica diabeticorum is associated to?,"Yes, necrobiosis lipoidica diabeticorum is associated with diabetes mellitus. This is stated explicitly in the context given, where it mentions that necrobiosis lipoidica diabeticorum is a rare","Context: diabeticorum or the clinical course of the lesion. We base our challenge to this  position on a critical review of the original data. And conclude on the  contrary, that necrobiosis lipoidica diabeticorum is usually associated with, Context: Necrobiosis lipoidica diabeticorum is a rare skin disorder, usually considered a  marker for diabetes mellitus. More than half of the patients with necrobiosis  lipoidica diabeticorum have diabetes mellitus, but less than one per cent of, Context: BACKGROUND: Necrobiosis lipoidica is a rare complication of diabetes mellitus.It  is said to occur more often in people with diabetes,a family history of  diabetes,tendency to develop diabetes mellitus and those with insulin dependent  diabetes., Context: In order to evaluate patients with necrobiosis lipoidica diabeticorum and to  compare them with age, sex, and duration of diabetes matched controls, 15  patients with necrobiosis were each matched with 5 control subjects with, Context: treatment employed in our index patient. CONCLUSION: That necrobiosis lipoidica diabeticorum does exist in our  environment and requires a high index of suspicion and scrupplelousness in  making the diagnosis and treating the patient., Context: is associated with the type 2 diabetes. Necrobiosis lipoidica is a granulomatous  skin disease of unknown etiology, associated mainly with diabetes mellitus. We  presented in this paper a morbid obese case of necrobiosis lipoidica","8733162, 8733162, 24283101, 8261754, 24283101, 23762652","Necrobiosis lipoidica diabeticorum (NLD) is a rare, granulomatous inflammatory skin disease of unknown origin, sometimes associated with diabetes mellitus.","23969033, 11259927, 12180894, 16060710, 12183729, 27016885, 19380665, 24575162, 20524475, 26975548, 18357585, 17429587, 2102235, 23762652, 24283101, 18092383, 3351015, 8733162, 7501550, 20537071, 730866, 19715570, 25266162, 18718195, 23595890, 7851128, 8261754, 18377597"
Which receptors does bimagrumab block?,"Yes, bimagrumab blocks activin type II receptors (ActRII). This is explicitly stated in the context given. The antibody inhibits these receptors, preventing the activity of myostatin and other negative skelet","Context: to their mode of action. The antiangiogenics block tumor angiogenesis by acting  on VEGF or its receptor. The main molecules are bevacizumab, sunitinib, and  sorafinib. HER inhibitors work by blocking these receptors, which control, Context: BACKGROUND: Bimagrumab is a human monoclonal antibody inhibitor of activin type  II receptors (ActRII), with anabolic action on skeletal muscle mass by blocking  binding of myostatin and other negative regulators of muscle growth. Bimagrumab, Context: pituitary, gonads and adrenal glands. AIM: To evaluate the effect of bimagrumab on the pituitary-gonadal and  pituitary-adrenal axes in humans. METHODS: Healthy men and women, aged 55 to 75 years, received bimagrumab, Context: is under evaluation for muscle wasting and associated functional loss in hip  fracture and sarcopenia, and in obesity. Bimagrumab also blocks other endogenous  ActRII ligands, such as activins, which act on the neurohormonal axes,, Context: A number of newer inhibitors are currently in clinical development with  different spectra of activity or mechanisms of receptor inhibition. These  include monoclonal antibodies, such as panitumumab and matuzumab; dual, Context: RATIONALE: Bimagrumab is a fully human monoclonal antibody that blocks the  activin type II receptors, preventing the activity of myostatin and other  negative skeletal muscle regulators.","19299048, 29566437, 29566437, 29566437, 16857825, 30095981",Bimagrumab blocks the activin type II receptors.,30095981
Is Sotatercept effective for Pulmonary Arterial Hypertension?,"Yes, sotatercept is effective in reducing pulmonary vascular resistance in patients with pulmonary arterial hypertension (PAH) who are receiving background therapy. This is evident from the least-squares mean difference","Context: METHODS: In this 24-week multicenter trial, we randomly assigned 106 adults who  were receiving background therapy for pulmonary arterial hypertension to receive  subcutaneous sotatercept at a dose of 0.3 mg per kilogram of body weight every 3, Context: BACKGROUND: Pulmonary arterial hypertension is characterized by pulmonary  vascular remodeling, cellular proliferation, and poor long-term outcomes.  Dysfunctional bone morphogenetic protein pathway signaling is associated with, Context: patient in the sotatercept 0.7-mg group died from cardiac arrest. CONCLUSIONS: Treatment with sotatercept resulted in a reduction in pulmonary  vascular resistance in patients receiving background therapy for pulmonary, Context: least-squares mean difference between the sotatercept 0.3-mg group and the  placebo group in the change from baseline to week 24 in pulmonary vascular  resistance was -145.8 dyn · sec · cm-5 (95% confidence interval [CI], -241.0 to, Context: (95% CI, -2.8 to 45.7). Sotatercept was also associated with a decrease in  N-terminal pro-B-type natriuretic peptide levels. Thrombocytopenia and an  increased hemoglobin level were the most common hematologic adverse events. One, Context: INTRODUCTION: Pulmonary arterial hypertension (PAH) is a serious primary illness  of the pulmonary arterioles, characterised by progressive precapillary pulmonary  hypertension. The conventional therapy for this condition is so-called specific","33789009, 33789009, 33789009, 33789009, 33789009, 17578162",Sotatercept was shown to be effective for Pulmonary Arterial Hypertension.,"33789009, 33733610"
List mutations that are implicated in the Gray Platelet Syndrome.,"Yes, according to the context, two mutations are implicated in the Gray Platelet Syndrome (GPS). The first one is a nonsense mutation in the gene encoding the transcription factor GFI1B. The second one","Context: The gray platelet syndrome is a rare inherited bleeding disorder characterized  by macrothrombocytopenia and deficiency of alpha (α)-granules in platelets. The  genetic defect responsible for gray platelet syndrome was recently identified in, Context: The gray platelet syndrome is a hereditary, usually autosomal recessive bleeding  disorder caused by a deficiency of alpha granules in platelets. We detected a  nonsense mutation in the gene encoding the transcription factor GFI1B (growth, Context: G10578 and DXS6797, which segregated with the platelet phenotype and included  the GATA1 gene. Sequencing of GATA1 revealed a G-to-A mutation at position 759  corresponding to amino acid change Arg216Gln. This mutation was previously, Context: Gray platelet syndrome (GPS) is a predominantly recessive platelet disorder that  is characterized by mild thrombocytopenia with large platelets and a paucity of  α-granules; these abnormalities cause mostly moderate but in rare cases severe, Context: The gray platelet syndrome is a hereditary, usually autosomal recessive bleeding  disorder caused by a deficiency of alpha granules in platelets. We detected a  nonsense mutation in the gene encoding the transcription factor GFI1B (growth, Context: We identified a family with gray platelet syndrome (GPS) segregating as a  sex-linked trait. Affected males had a mild bleeding disorder, thrombocytopenia,  and large agranular platelets characteristic of GPS, while obligate carrier","23100277, 24325358, 17209061, 21765411, 24325358, 17209061",GFI1B and NBEAL2 mutations are implicated in the Gray Platelet Syndrome.,"23861251, 21765412, 25258341, 21765413, 24325358, 23100277"
What are reactive metabolites?,Reactive metabolites are molecules formed during the bioactivation of certain drugs. They can bind to cellular proteins and are believed to be responsible for most idiosyncratic drug reactions. The context suggests that these metabolites,"Context: idiosyncratic reactions form reactive metabolites to some degree. Covalent  binding of reactive metabolites to cellular proteins has also been shown in many  cases. However, studies to reveal the role of reactive metabolites and their, Context: metabolites. Strategies for dealing with reactive metabolites are reviewed. In  conclusion, we discuss the challenges and future needs in this field of  research., Context: Reactive metabolites are believed to be responsible for most idiosyncratic drug  reactions. It is often assumed that if a reactive metabolite is found, it must  be responsible for the idiosyncratic reactions associated with that drug., Context: to screen trapped reactive metabolites. The bioactivation of pulegone,  acetaminophen, and clozapine were reexamined by using this metabolomic approach.  In all these cases, a large number of trapped reactive metabolites were readily, Context: metabolites. Strategies for dealing with reactive metabolites are reviewed. In  conclusion, we discuss the challenges and future needs in this field of  research., Context: idiosyncratic reactions form reactive metabolites to some degree. Covalent  binding of reactive metabolites to cellular proteins has also been shown in many  cases. However, studies to reveal the role of reactive metabolites and their","12093356, 16967439, 17145699, 21469730, 16967439, 12093356","Reactive metabolites are generated when a small molecule, commonly a drug or hydrocarbon, is broken down in the body. Reactive metabolites can cause cancer and other diseases as well as hepatoxicty. ","9144833, 21504003, 27031942, 21769097, 16967439, 22681489, 18788755, 25174933, 159767, 21469730, 26005795, 20391594, 25851819, 23090860, 12093356, 26627130, 26735163, 25363902, 25312212, 21148252, 17145699, 21083235, 16235238, 8987247, 9614200, 1628536"
Can acupuncture cause spinal epidural hematoma?,"Yes, according to the context, acupuncture can cause spinal epidural hematoma. This is because the text presents the first report of cervical epidural hematoma after dry needling, which is a form of ac","Context: unusual and only a few cases of epidural hematoma after acupuncture have been  reported in the literature. We are presenting the first report of acute cervical  epidural hematoma after dry needling., Context: while two patients presented with post-procedural neurological deficits.  Surgical evacuation of the hematoma was performed in two patients while in  remaining two patients, surgery was initially recommended but not performed, Context: Unintentional acupuncture needling of the thoracic spinal canal produced a  spinal epidural hematoma and subarachnoid hemorrhage. This case demonstrates  that patients are sometimes reluctant to disclose folk medical treatments to, Context: Spinal epidural hematoma is a rare complication associated with pain control  procedures such as facet block, acupuncture, epidural injection, etc. Although  it is an uncommon cause of acute myelopathy, and it may require surgical, Context: management of pain control, we encountered the first case of SDH after  acupuncture. PURPOSE: The purpose of this case report was to present the first case of  subdural hematoma after acupuncture and the reasons for the risks of blind, Context: BACKGROUND CONTEXT: Subdural spinal hematoma (SDH) is a very rare entity;  however, it can lead to serious complications resulting from injuries to the  spinal cord and roots. Although acupuncture has been a popular method for the","21289580, 21082060, 8456713, 21082060, 24094991, 24094991","Yes, acupuncture can cause spinal epidural hematoma.","8456713, 21082060, 21289580, 27651774, 24094991, 25459742"
List features of the Triple A syndrome.,"Yes, the context provides information about the features of Triple A syndrome. The features are neurological abnormalities, dermatological abnormalities, alacrima (absence of tears), and ACTH insensitivity leading","Context: parents are both heterozygous carriers of the mutation. The affected twin  brother unfortunately died from hypoglycaemic shock, despite a normal cortisol  rise in an ACTH stimulation test. Further, triple A syndrome patients carrying, Context: syndrome are neurological and dermatological abnormalities. Until the discovery  of the AAAS gene as the responsible gene in triple A syndrome, the diagnosis was  based on characteristic clinical features. Here we present the clinical and, Context: molecular genetic data which demonstrated the marked phenotypic variability in  three unrelated patients with triple A syndrome. The final diagnosis of triple A  syndrome was confirmed by molecular analysis. In one patient with isolated, Context: Triple A syndrome. Our aim is to inform pediatric surgeons about the existence  of this rare syndrome and to highlight the need for suspicion of alacrima and  ACTH insensitivity in cases of pediatric achalasia. Triple A syndrome should be, Context: syndrome are neurological and dermatological abnormalities. Until the discovery  of the AAAS gene as the responsible gene in triple A syndrome, the diagnosis was  based on characteristic clinical features. Here we present the clinical and, Context: North Africa and Europe. The majority of mutations were homozygous. We have  identified 20 families with between two and four of the clinical features  associated with the triple A syndrome. Sequencing of the triple A gene revealed","18551317, 12752575, 12752575, 27385299, 12752575, 12429595","Triple A (Allgrove) syndrome is a rare autosomal recessive disorder characterized by cardinal features of adrenal insufficiency, achalasia, and alacrimia. It is frequently associated with neurological manifestations like polyneuropathy.","22000320, 12530689, 11196451, 30069287, 29255950, 27895694, 23691407, 29874194, 11815731, 18551317, 21656342, 16970037, 26354489, 15666842, 12429595, 12752575"
"In clinical trials, the H3 R antagonist CEP-26401 has a positive effect on cognition, yes or no?","Yes, according to the context, CEP-26401 has shown potential in enhancing cognition. The results of studies with single and multiple administrations of CEP-26401 in healthy subjects suggest that this novel","Context: in clinical trials., Context: The number of global clinical trials including Japan is increasing but still  much lower than those including the USA and Europe. The regulatory requirements  for clinical trials have been harmonized among Japan, USA, and Europe, and the, Context: pharmacokinetic data. CEP-26401 was generally well tolerated up to 0.5 mg/day  with most common treatment related adverse events being headache and insomnia.  Further clinical studies are required to establish the potential of low-dose, Context: studies with single (0.02 to 5 mg) or multiple administration (0.02 to 0.5 mg  once daily) of CEP-26401 were conducted in healthy subjects. Plasma and urine  samples were collected to investigate CEP-26401 pharmacokinetics., Context: results demonstrate potent behavioral effects of CEP-26401 in rodent models and  suggest that this novel H₃R antagonist may have therapeutic utility in the  treatment of cognitive and attentional disorders. CEP-26401 may also have, Context: CEP-26401 in cognition enhancement.","24309100, 30710642, 27222271, 27222271, 22001260, 27222271",The H3 R antagonist CEP-26401 had an effect on cognition.,"18469850, 22001260, 27222271"
Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?,"Yes, the context provides information about the organs mostly affected by SLE. The text mentions that the heart, kidney, hematologic system, and mucocutaneous areas are among the commonly impacted areas in SLE","Context: Systemic lupus erythematosus (SLE) is an autoimmune systemic disease with  multiple organ involvement with high morbidity and mortality rate. Among the  severe potential fatal complications are those of the central and peripheral, Context: BACKGROUND: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease  with wide clinical features ranging from cutaneous manifestations to systemic  disease. Skin is one of the most commonly affected organs in SLE., Context: Lupus erythematosus (LE) includes a broad spectrum of diseases from a  cutaneous-limited type to a systemic type. Systemic lupus erythematosus (SLE) is  a systemic autoimmune disease which affects multiple organs. Cutaneous lupus, Context: The heart is one of the most frequently affected organs in SLE. Any part of the  heart can be affected, including the pericardium, myocardium, coronary arteries,  valves, and the conduction system. In addition to pericarditis and myocarditis,, Context: enzymes. The median SLE Disease Activity Index was 8.0 (range 0-20.0) at the  time of AAC. Other affected organs in SLE-AAC included kidney (11, 84.6%) and  hematologic system (11, 84.6%), followed by mucocutaneous (seven, 53.8%),, Context: BACKGROUND: Systemic lupus erythematosus (SLE) may involve any number of organ  systems and varies greatly in the severity and type of involvement. Cutaneous  manifestations of SLE are equally numerous and varied throughout the course of","26366317, 25186992, 21767292, 24268009, 28355987, 7607795","In systemic lupus erythematosus (SLE), brain and kidney are the most frequently affected organs. The heart is one of the most frequently affected organs in SLE. Skin is one of the most commonly affected organs in SLE. Other affected organs in SLE-AAC included hematologic system (11, 84.6%), followed by mucocutaneous (seven, 53.8%), musculoskeletal (seven, 53.8%) and neuropsychiatric (two, 15.4%) systems.","24268009, 25186992, 7588946, 28355987, 19758166, 21767292"
